| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.917 | 0.004 | 0.917 | Cyclophilin D inhibitor | 0.701 0.014 DB01914 0.345 0.126 DB09526 0.649 0.02 DBMET02100 0.434 0.073 DBMET02101 | ||
| 0.861 | 0.003 | 0.861 | Angiogenesis stimulant | 0.335 0.037 DB09526 0.31 0.046 DBMET02100 0.787 0.004 DBMET02101 | ||
| 0.861 | 0.005 | 0.861 | Caspase 9 stimulant | 0.411 0.104 DB01914 0.749 0.018 DB09526 0.418 0.1 DBMET02100 0.259 0.243 DBMET02101 | ||
| 0.86 | 0.004 | 0.86 | Antioxidant | 0.242 0.088 DB01914 0.649 0.008 DB09526 0.34 0.049 DBMET02100 0.676 0.007 DBMET02101 | ||
| 0.861 | 0.008 | 0.861 | Antiinflammatory | 0.615 0.049 DB01914 0.479 0.097 DB09526 0.708 0.029 DBMET02100 0.595 0.055 DBMET02101 | ||
| 0.844 | 0.001 | 0.844 | Amylase inhibitor | 0.77 0.002 DB01914 0.403 0.009 DB09526 0.387 0.01 DBMET02100 | ||
| 0.844 | 0.002 | 0.938 | Alpha-N-acetylglucosaminidase inhibitor | 0.938 0.001 DB01914 0.656 0.003 DB09526 0.484 0.006 DBMET02100 0.233 0.026 DBMET02101 | DB01914 | |
| 0.842 | 0.004 | 0.926 | Hypoglycemic | 0.926 0.003 DB01914 0.418 0.025 DB09526 0.533 0.013 DBMET02100 | DB01914 | |
| 0.837 | 0.004 | 0.837 | Cholesterol antagonist | 0.382 0.053 DB01914 0.577 0.021 DB09526 0.684 0.009 DBMET02100 0.666 0.011 DBMET02101 | ||
| 0.809 | 0.003 | 0.809 | 5 Hydroxytryptamine release stimulant | 0.261 0.084 DB01914 0.73 0.005 DB09526 0.279 0.077 DBMET02100 0.229 0.1 DBMET02101 | ||
| 0.778 | 0.002 | 0.778 | Melanin inhibitor | 0.216 0.035 DB01914 0.357 0.015 DB09526 0.281 0.024 DBMET02100 0.137 0.102 DBMET02101 | ||
| 0.77 | 0.004 | 0.77 | Free radical scavenger | 0.656 0.006 DB09526 0.339 0.041 DBMET02100 0.396 0.029 DBMET02101 | ||
| 0.738 | 0.004 | 0.738 | Monophenol monooxygenase inhibitor | 0.294 0.018 DB09526 0.242 0.025 DBMET02100 0.214 0.03 DBMET02101 | ||
| 0.753 | 0.023 | 0.753 | Apoptosis agonist | 0.553 0.06 DB09526 0.299 0.173 DBMET02100 | ||
| 0.754 | 0.025 | 0.754 | Alpha-glucosidase inhibitor | 0.508 0.078 DB01914 0.397 0.116 DB09526 0.246 0.19 DBMET02101 | ||
| 0.738 | 0.017 | 0.738 | Transcription factor NF kappa B inhibitor | 0.188 0.182 DB01914 0.437 0.056 DB09526 0.394 0.065 DBMET02100 0.294 0.097 DBMET02101 | ||
| 0.703 | 0.008 | 0.703 | Antithrombotic | 0.322 0.076 DB01914 0.333 0.071 DB09526 0.429 0.043 DBMET02100 0.56 0.021 DBMET02101 | ||
| 0.681 | 0.006 | 0.681 | Nitric oxide antagonist | 0.186 0.073 DB01914 0.343 0.033 DB09526 0.262 0.048 DBMET02100 0.178 0.077 DBMET02101 | ||
| 0.678 | 0.005 | 0.678 | Apoptosis antagonist | 0.266 0.112 DB01914 0.397 0.039 DB09526 0.249 0.129 DBMET02100 | ||
| 0.683 | 0.01 | 0.683 | Antibacterial | 0.45 0.057 DB01914 0.387 0.083 DB09526 0.594 0.02 DBMET02100 0.532 0.033 DBMET02101 | ||
| 0.669 | 0.003 | 0.669 | Mediator release inhibitor | 0.087 0.085 DB01914 0.146 0.03 DB09526 | ||
| 0.666 | 0.005 | 0.666 | Vasodilator, coronary | 0.374 0.045 DB01914 0.381 0.042 DB09526 0.308 0.081 DBMET02100 | ||
| 0.655 | 0.004 | 0.655 | NOS3 expression enhancer | 0.426 0.007 DB09526 0.198 0.041 DBMET02100 0.136 0.089 DBMET02101 | ||
| 0.643 | 0.004 | 0.643 | Hepatoprotectant | 0.344 0.02 DB01914 0.278 0.036 DB09526 0.251 0.043 DBMET02100 0.318 0.025 DBMET02101 | ||
| 0.639 | 0.003 | 0.639 | Neurotrophic factor enhancer | 0.162 0.121 DB01914 0.372 0.007 DB09526 0.257 0.034 DBMET02100 0.156 0.129 DBMET02101 | ||
| 0.638 | 0.004 | 0.638 | Interleukin agonist | 0.2 0.121 DB01914 0.358 0.027 DB09526 0.296 0.05 DBMET02100 | ||
| 0.63 | 0.002 | 0.63 | NADH dehydrogenase inhibitor | 0.437 0.004 DB01914 0.365 0.005 DB09526 0.241 0.008 DBMET02100 0.192 0.011 DBMET02101 | ||
| 0.624 | 0.002 | 0.796 | Triose-phosphate isomerase inhibitor | 0.796 0.001 DB01914 0.366 0.004 DB09526 0.26 0.006 DBMET02100 0.661 0.001 DBMET02101 | DB01914 | |
| 0.618 | 0.01 | 0.803 | Immunomodulator | 0.803 0.004 DB01914 | DB01914 | |
| 0.614 | 0.007 | 0.614 | DNA synthesis inhibitor | 0.49 0.014 DB01914 0.369 0.026 DB09526 0.402 0.021 DBMET02100 0.248 0.068 DBMET02101 | ||
| 0.604 | 0.001 | 0.604 | Alpha-mannosidase inhibitor | 0.549 0.001 DB01914 0.103 0.006 DB09526 0.095 0.007 DBMET02100 0.14 0.004 DBMET02101 | ||
| 0.597 | 0.001 | 0.597 | Mannosidase inhibitor | 0.536 0.001 DB01914 0.096 0.006 DB09526 0.093 0.006 DBMET02100 0.139 0.004 DBMET02101 | ||
| 0.609 | 0.015 | 0.609 | Vasodilator, peripheral | 0.276 0.11 DB01914 0.459 0.038 DB09526 0.27 0.113 DBMET02100 | ||
| 0.594 | 0.003 | 0.594 | Protein kinase stimulant | 0.136 0.079 DB01914 0.279 0.02 DB09526 0.301 0.017 DBMET02100 | ||
| 0.605 | 0.016 | 0.605 | Immunostimulant | 0.421 0.044 DB01914 0.306 0.077 DB09526 0.372 0.058 DBMET02100 0.392 0.052 DBMET02101 | ||
| 0.591 | 0.004 | 0.591 | Interleukin 2 agonist | 0.217 0.161 DB01914 0.368 0.038 DB09526 0.395 0.029 DBMET02100 | ||
| 0.587 | 0.011 | 0.587 | Caspase 3 stimulant | 0.209 0.156 DB01914 0.486 0.022 DB09526 | ||
| 0.582 | 0.008 | 0.582 | Tumour necrosis factor alpha release inhibitor | 0.18 0.127 DB09526 0.205 0.105 DBMET02100 | ||
| 0.571 | 0.001 | 0.591 | UDP-glucose 4-epimerase inhibitor | 0.591 0.001 DB01914 0.416 0.005 DB09526 0.346 0.008 DBMET02100 0.14 0.032 DBMET02101 | DB01914 | |
| 0.579 | 0.016 | 0.579 | Immunosuppressant | 0.48 0.039 DB01914 0.311 0.108 DB09526 0.405 0.061 DBMET02100 | ||
| 0.57 | 0.009 | 0.57 | DNA damaging | 0.308 0.054 DB09526 | ||
| 0.563 | 0.002 | 0.563 | Selectin antagonist | 0.137 0.02 DB01914 0.073 0.041 DB09526 0.345 0.004 DBMET02100 0.359 0.004 DBMET02101 | ||
| 0.553 | 0.003 | 0.553 | Hexokinase inhibitor | 0.438 0.004 DB01914 0.263 0.015 DB09526 0.293 0.012 DBMET02100 | ||
| 0.565 | 0.016 | 0.627 | 5 Hydroxytryptamine release inhibitor | 0.467 0.044 DB01914 0.627 0.008 DB09526 0.425 0.064 DBMET02100 0.283 0.185 DBMET02101 | DB09526 | |
| 0.552 | 0.004 | 0.552 | Aldehyde dehydrogenase inhibitor | 0.537 0.004 DB01914 0.372 0.006 DB09526 0.166 0.039 DBMET02100 0.136 0.057 DBMET02101 | ||
| 0.539 | 0.003 | 0.539 | Expectorant | 0.232 0.015 DB01914 0.222 0.016 DB09526 0.211 0.018 DBMET02100 0.103 0.066 DBMET02101 | ||
| 0.536 | 0.004 | 0.536 | Interferon gamma antagonist | 0.158 0.068 DB01914 0.309 0.019 DB09526 0.348 0.014 DBMET02100 0.129 0.113 DBMET02101 | ||
| 0.515 | 0.002 | 0.629 | Phosphofructokinase-1 inhibitor | 0.629 0.001 DB01914 0.261 0.007 DB09526 0.226 0.009 DBMET02100 0.158 0.017 DBMET02101 | DB01914 | |
| 0.513 | 0.003 | 0.513 | Cyclooxygenase 3 inhibitor | 0.22 0.013 DB09526 0.197 0.02 DBMET02100 | ||
| 0.518 | 0.01 | 0.518 | RNA-directed DNA polymerase inhibitor | 0.211 0.084 DB01914 0.413 0.017 DB09526 0.236 0.059 DBMET02100 0.499 0.011 DBMET02101 | ||
| 0.515 | 0.007 | 0.515 | Anesthetic general | 0.173 0.092 DB01914 0.444 0.012 DB09526 0.262 0.045 DBMET02100 | ||
| 0.511 | 0.005 | 0.538 | Platelet adhesion inhibitor | 0.234 0.055 DB09526 0.136 0.123 DBMET02100 0.538 0.005 DBMET02101 | DBMET02101 | |
| 0.497 | 0.003 | 0.497 | AMP-activated protein kinase stimulant | 0.166 0.019 DB09526 0.214 0.009 DBMET02100 | ||
| 0.497 | 0.007 | 0.497 | Cyclic AMP phosphodiesterase inhibitor | 0.338 0.029 DB09526 0.281 0.05 DBMET02100 | ||
| 0.514 | 0.024 | 0.562 | Histamine release inhibitor | 0.417 0.067 DB01914 0.562 0.014 DB09526 0.468 0.041 DBMET02100 0.513 0.024 DBMET02101 | DB09526 | |
| 0.494 | 0.005 | 0.494 | Lipid peroxidase inhibitor | 0.464 0.006 DB09526 0.161 0.061 DBMET02100 0.3 0.019 DBMET02101 | ||
| 0.469 | 0.005 | 0.469 | Alkylator | 0.355 0.009 DB01914 0.188 0.03 DB09526 0.103 0.085 DBMET02100 0.157 0.043 DBMET02101 | ||
| 0.458 | 0.005 | 0.458 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.155 0.138 DB01914 0.388 0.009 DB09526 0.297 0.024 DBMET02100 0.162 0.122 DBMET02101 | ||
| 0.451 | 0.005 | 0.485 | Hemostatic | 0.119 0.116 DB01914 0.173 0.047 DB09526 0.149 0.07 DBMET02100 0.485 0.005 DBMET02101 | DBMET02101 | |
| 0.449 | 0.004 | 0.449 | Xanthine oxidase inhibitor | 0.223 0.015 DB09526 0.181 0.024 DBMET02100 | ||
| 0.447 | 0.004 | 0.447 | Beta glucuronidase inhibitor | 0.203 0.012 DB09526 0.221 0.01 DBMET02100 | ||
| 0.457 | 0.015 | 0.457 | Vasodilator | 0.203 0.102 DB01914 0.289 0.052 DB09526 | ||
| 0.436 | 0.003 | 0.436 | Photosensitizer | 0.097 0.094 DB01914 0.221 0.009 DB09526 0.186 0.016 DBMET02100 0.124 0.053 DBMET02101 | ||
| 0.436 | 0.005 | 0.436 | Topoisomerase I inhibitor | 0.272 0.014 DB09526 0.115 0.059 DBMET02101 | ||
| 0.431 | 0.003 | 0.431 | Nitric-oxide synthase stimulant | 0.225 0.054 DB01914 0.367 0.004 DB09526 0.245 0.036 DBMET02100 0.201 0.088 DBMET02101 | ||
| 0.431 | 0.003 | 0.431 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.239 0.011 DB01914 0.324 0.005 DB09526 0.231 0.012 DBMET02100 0.085 0.073 DBMET02101 | ||
| 0.429 | 0.005 | 0.429 | Peptidyltransferase inhibitor | 0.263 0.042 DB01914 0.304 0.023 DB09526 0.271 0.037 DBMET02100 | ||
| 0.431 | 0.01 | 0.431 | Non-steroidal antiinflammatory agent | 0.15 0.115 DB01914 0.248 0.044 DB09526 0.22 0.057 DBMET02100 | ||
| 0.425 | 0.021 | 0.556 | Amyloid beta aggregation inhibitor | 0.556 0.01 DB09526 | DB09526 | |
| 0.405 | 0.003 | 0.405 | DNA repair enzyme inhibitor | 0.162 0.022 DB09526 | ||
| 0.396 | 0.004 | 0.679 | Carbonic anhydrase XIII inhibitor | 0.079 0.05 DB01914 0.234 0.01 DB09526 0.084 0.047 DBMET02100 0.679 0.003 DBMET02101 | DBMET02101 | |
| 0.398 | 0.006 | 0.41 | Cell wall synthesis inhibitor | 0.173 0.045 DB01914 0.238 0.018 DB09526 0.234 0.019 DBMET02100 0.41 0.005 DBMET02101 | DBMET02101 | |
| 0.396 | 0.006 | 0.396 | Insulin secretagoues | 0.172 0.054 DB09526 0.137 0.089 DBMET02100 | ||
| 0.393 | 0.008 | 0.437 | Interleukin 6 antagonist | 0.437 0.005 DB01914 0.202 0.039 DB09526 0.254 0.022 DBMET02100 | DB01914 | |
| 0.382 | 0.012 | 0.382 | DNA methylase inhibitor | 0.277 0.035 DB09526 0.158 0.111 DBMET02100 | ||
| 0.373 | 0.004 | 0.373 | ATPase inhibitor | 0.176 0.063 DB01914 0.25 0.014 DB09526 0.21 0.03 DBMET02100 | ||
| 0.381 | 0.013 | 0.418 | Thrombolytic | 0.161 0.074 DB09526 0.418 0.01 DBMET02100 0.339 0.018 DBMET02101 | DBMET02100 | |
| 0.377 | 0.011 | 0.377 | Topoisomerase II inhibitor | 0.353 0.013 DB09526 0.129 0.061 DBMET02101 | ||
| 0.365 | 0.004 | 0.513 | Mannose-6-phosphate isomerase inhibitor | 0.513 0.002 DB01914 0.285 0.007 DB09526 0.143 0.071 DBMET02100 | DB01914 | |
| 0.396 | 0.041 | 0.396 | Spasmolytic | 0.314 0.065 DB09526 0.268 0.084 DBMET02101 | ||
| 0.355 | 0.001 | 0.355 | Sodium/glucose cotransporter inhibitor | 0.045 0.006 DB09526 0.047 0.005 DBMET02100 | ||
| 0.359 | 0.006 | 0.499 | Cystathionine beta-synthase inhibitor | 0.097 0.08 DB01914 0.499 0.004 DB09526 0.322 0.008 DBMET02100 0.175 0.031 DBMET02101 | DB09526 | |
| 0.382 | 0.032 | 0.382 | Antiamyloidogenic | 0.282 0.058 DB09526 | ||
| 0.384 | 0.034 | 0.384 | Hypoxia-inducible factor 1 alpha inhibitor | 0.204 0.147 DB01914 0.368 0.039 DB09526 0.21 0.141 DBMET02100 0.19 0.164 DBMET02101 | ||
| 0.356 | 0.007 | 0.356 | Antineoplastic antibiotic | 0.167 0.027 DB01914 0.107 0.043 DB09526 0.124 0.037 DBMET02100 0.105 0.044 DBMET02101 | ||
| 0.345 | 0.003 | 0.486 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.486 0.001 DB01914 0.177 0.007 DB09526 0.068 0.028 DBMET02100 0.055 0.04 DBMET02101 | DB01914 | |
| 0.355 | 0.014 | 0.472 | Phospholipase C inhibitor | 0.182 0.058 DB01914 0.384 0.012 DB09526 0.341 0.015 DBMET02100 0.472 0.007 DBMET02101 | DBMET02101 | |
| 0.342 | 0.008 | 0.342 | Cell adhesion inhibitor | |||
| 0.338 | 0.016 | 0.338 | DNA methyltransferase I inhibitor | 0.289 0.03 DB09526 0.159 0.095 DBMET02100 | ||
| 0.324 | 0.003 | 0.324 | Phosphodiesterase 6D inhibitor | 0.134 0.015 DB09526 0.087 0.083 DBMET02100 0.109 0.037 DBMET02101 | ||
| 0.348 | 0.036 | 0.348 | Hypolipemic | 0.242 0.071 DB01914 0.193 0.099 DB09526 0.247 0.069 DBMET02100 | ||
| 0.311 | 0.005 | 0.386 | Carbonic anhydrase III inhibitor | 0.337 0.005 DB09526 0.15 0.028 DBMET02100 0.386 0.004 DBMET02101 | DBMET02101 | |
| 0.316 | 0.01 | 0.316 | DNA polymerase I inhibitor | 0.228 0.021 DB09526 0.203 0.027 DBMET02100 | ||
| 0.308 | 0.003 | 0.308 | Phosphorylase inhibitor | 0.275 0.004 DB01914 0.06 0.025 DB09526 0.11 0.012 DBMET02100 | ||
| 0.294 | 0.004 | 0.294 | CF transmembrane conductance regulator agonist | 0.277 0.005 DB09526 0.236 0.009 DBMET02100 0.129 0.122 DBMET02101 | ||
| 0.29 | 0.004 | 0.29 | Histone deacetylase SIRT1 stimulant | 0.131 0.014 DB09526 | ||
| 0.29 | 0.004 | 0.29 | Histone deacetylase stimulant | 0.131 0.014 DB09526 | ||
| 0.29 | 0.004 | 0.29 | Mucolytic | 0.229 0.009 DB01914 0.219 0.01 DB09526 0.19 0.016 DBMET02100 0.128 0.048 DBMET02101 | ||
| 0.289 | 0.004 | 0.289 | Transcription factor NF kappa B stimulant | 0.091 0.05 DB09526 0.094 0.045 DBMET02100 | ||
| 0.281 | 0.001 | 0.442 | Glucose-6-phosphate isomerase inhibitor | 0.442 0 DB01914 0.126 0.003 DB09526 0.09 0.006 DBMET02100 0.081 0.008 DBMET02101 | DB01914 | |
| 0.29 | 0.015 | 0.29 | Adenylate cyclase inhibitor | 0.217 0.023 DB09526 0.095 0.089 DBMET02100 | ||
| 0.275 | 0.004 | 0.275 | Glutamate release inhibitor | 0.084 0.079 DB01914 0.188 0.005 DB09526 0.144 0.011 DBMET02100 | ||
| 0.279 | 0.01 | 0.4 | Interleukin 4 antagonist | 0.4 0.005 DB09526 0.318 0.008 DBMET02100 | DB09526 | |
| 0.353 | 0.086 | 0.415 | Antiobesity | 0.382 0.073 DB01914 0.415 0.06 DBMET02101 | DBMET02101 | |
| 0.274 | 0.009 | 0.291 | Topoisomerase II alpha inhibitor | 0.291 0.008 DB09526 | DB09526 | |
| 0.269 | 0.004 | 0.269 | Carbonic anhydrase XIV inhibitor | 0.103 0.01 DB09526 0.043 0.041 DBMET02100 0.072 0.019 DBMET02101 | ||
| 0.264 | 0.001 | 0.264 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.021 DB01914 0.057 0.005 DB09526 0.05 0.006 DBMET02100 | ||
| 0.267 | 0.004 | 0.267 | Interferon agonist | 0.138 0.012 DB01914 0.107 0.024 DB09526 0.093 0.035 DBMET02101 | ||
| 0.364 | 0.107 | 0.581 | Calcium channel L-type activator | 0.581 0.008 DB09526 0.408 0.076 DBMET02100 | DB09526 | |
| 0.259 | 0.004 | 0.259 | Toll-Like receptor 4 antagonist | 0.171 0.012 DB09526 0.11 0.055 DBMET02100 | ||
| 0.26 | 0.007 | 0.271 | Alcohol dehydrogenase inhibitor | 0.172 0.016 DB01914 0.271 0.006 DB09526 0.098 0.054 DBMET02100 0.1 0.052 DBMET02101 | DB09526 | |
| 0.254 | 0.005 | 0.254 | Vanilloid 1 agonist | 0.188 0.015 DB09526 0.126 0.074 DBMET02100 0.16 0.029 DBMET02101 | ||
| 0.246 | 0.005 | 0.246 | Interleukin 12 antagonist | 0.185 0.007 DB09526 0.102 0.05 DBMET02100 | ||
| 0.246 | 0.005 | 0.246 | Thioredoxin inhibitor | 0.156 0.015 DB09526 | ||
| 0.323 | 0.082 | 0.626 | Angiogenesis inhibitor | 0.626 0.014 DBMET02101 | DBMET02101 | |
| 0.292 | 0.055 | 0.372 | Platelet antagonist | 0.372 0.033 DBMET02100 0.191 0.108 DBMET02101 | DBMET02100 | |
| 0.242 | 0.009 | 0.32 | Carbonic anhydrase VI inhibitor | 0.284 0.007 DB09526 0.099 0.04 DBMET02100 0.32 0.005 DBMET02101 | DBMET02101 | |
| 0.234 | 0.005 | 0.251 | Adenylate cyclase stimulant | 0.176 0.029 DB01914 0.251 0.004 DB09526 0.187 0.021 DBMET02100 0.239 0.005 DBMET02101 | DB09526 | |
| 0.255 | 0.032 | 0.255 | Insulin sensitizer | 0.162 0.117 DB01914 0.247 0.036 DB09526 0.196 0.077 DBMET02100 0.189 0.085 DBMET02101 | ||
| 0.222 | 0.005 | 0.222 | Heat shock protein 70 antagonist | 0.207 0.005 DB09526 0.19 0.008 DBMET02100 | ||
| 0.219 | 0.002 | 0.219 | Heparanase inhibitor | 0.07 0.011 DB01914 0.066 0.015 DB09526 0.087 0.005 DBMET02100 0.097 0.004 DBMET02101 | ||
| 0.225 | 0.02 | 0.225 | DNA intercalator | 0.107 0.067 DB09526 | ||
| 0.204 | 0.009 | 0.204 | Sphingomyelinase inhibitor | 0.187 0.012 DB01914 0.162 0.02 DB09526 | ||
| 0.193 | 0.004 | 0.193 | Interferon inducer | 0.059 0.057 DB01914 0.088 0.018 DB09526 0.079 0.025 DBMET02101 | ||
| 0.186 | 0.004 | 0.186 | Glycine receptor antagonist | 0.137 0.011 DB09526 0.131 0.013 DBMET02100 0.182 0.004 DBMET02101 | ||
| 0.185 | 0.005 | 0.185 | Protein 50S ribosomal subunit inhibitor | 0.11 0.011 DB01914 0.152 0.006 DBMET02100 | ||
| 0.194 | 0.016 | 0.382 | Adenylate kinase inhibitor | 0.382 0.004 DB01914 0.295 0.007 DB09526 0.186 0.017 DBMET02100 0.175 0.019 DBMET02101 | DB01914 | |
| 0.183 | 0.009 | 0.726 | Estrogen agonist | 0.579 0.003 DB09526 0.095 0.019 DBMET02100 0.726 0.002 DBMET02101 | DBMET02101 | |
| 0.178 | 0.005 | 0.178 | Phosphodiesterase VI inhibitor | 0.087 0.032 DB09526 | ||
| 0.18 | 0.007 | 0.204 | Ca2+-transporting ATPase inhibitor | 0.167 0.016 DB01914 0.204 0.003 DB09526 0.18 0.007 DBMET02100 0.153 0.036 DBMET02101 | DB09526 | |
| 0.174 | 0.005 | 0.174 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.146 0.008 DB09526 0.093 0.019 DBMET02100 | ||
| 0.174 | 0.005 | 0.2 | GABA aminotransferase inhibitor | 0.069 0.063 DB01914 0.2 0.004 DB09526 0.183 0.005 DBMET02100 | DB09526 | |
| 0.193 | 0.027 | 0.248 | Toll-Like receptor 2 antagonist | 0.158 0.047 DB01914 0.248 0.009 DB09526 0.128 0.07 DBMET02100 | DB09526 | |
| 0.164 | 0.004 | 0.164 | Na+ K+ transporting ATPase inhibitor | 0.116 0.019 DB01914 0.118 0.018 DB09526 0.108 0.024 DBMET02100 0.124 0.014 DBMET02101 | ||
| 0.167 | 0.009 | 0.171 | Aldose reductase inhibitor | 0.045 0.044 DB01914 0.171 0.009 DB09526 0.164 0.009 DBMET02101 | DB09526 | |
| 0.179 | 0.026 | 0.239 | Microtubule formation inhibitor | 0.239 0.012 DB01914 0.185 0.024 DB09526 0.155 0.035 DBMET02100 | DB01914 | |
| 0.178 | 0.025 | 0.178 | Beta amyloid protein antagonist | 0.159 0.034 DB09526 | ||
| 0.151 | 0.004 | 0.216 | Glucosylceramidase inhibitor | 0.216 0.003 DB01914 0.088 0.012 DB09526 0.056 0.037 DBMET02100 | DB01914 | |
| 0.151 | 0.007 | 0.151 | ATPase (Vacuolar H+) inhibitor | 0.1 0.04 DB09526 | ||
| 0.257 | 0.12 | 0.417 | Sodium/bile acid cotransporter inhibitor | 0.417 0.013 DB09526 0.385 0.022 DBMET02100 0.362 0.033 DBMET02101 | DB09526 | |
| 0.137 | 0.002 | 0.137 | Antibiotic Aminoglycoside-like | 0.035 0.026 DB01914 0.041 0.02 DBMET02100 | ||
| 0.145 | 0.012 | 0.234 | Carbamoyl phosphate synthetase inhibitor | 0.234 0.006 DB01914 0.215 0.007 DB09526 0.098 0.021 DBMET02100 0.125 0.015 DBMET02101 | DB01914 | |
| 0.155 | 0.021 | 0.222 | Uric acid excretion stimulant | 0.222 0.01 DB09526 0.099 0.053 DBMET02100 | DB09526 | |
| 0.175 | 0.045 | 0.293 | Alkaline phosphatase inhibitor | 0.216 0.028 DB09526 0.293 0.013 DBMET02101 | DBMET02101 | |
| 0.208 | 0.08 | 0.396 | Interleukin antagonist | 0.134 0.131 DB01914 0.396 0.031 DB09526 0.151 0.117 DBMET02100 | DB09526 | |
| 0.181 | 0.053 | 0.243 | Arachidonic acid antagonist | 0.199 0.034 DB01914 0.243 0.007 DB09526 0.22 0.017 DBMET02100 0.201 0.033 DBMET02101 | DB09526 | |
| 0.228 | 0.108 | 0.292 | Gastrin inhibitor | 0.292 0.039 DB09526 0.197 0.154 DBMET02100 | DB09526 | |
| 0.145 | 0.025 | 0.731 | Estrogen antagonist | 0.731 0.003 DB09526 0.166 0.019 DBMET02100 0.208 0.012 DBMET02101 | DB09526 | |
| 0.131 | 0.012 | 0.131 | T cell inhibitor | |||
| 0.128 | 0.01 | 0.24 | Neuraminidase (influenza) inhibitor | 0.24 0.004 DB01914 0.114 0.013 DB09526 0.15 0.007 DBMET02100 0.217 0.004 DBMET02101 | DB01914 | |
| 0.179 | 0.062 | 0.832 | Anticoagulant | 0.173 0.065 DBMET02100 0.832 0.004 DBMET02101 | DBMET02101 | |
| 0.132 | 0.015 | 0.144 | Carbonic anhydrase XII inhibitor | 0.07 0.029 DB09526 0.144 0.013 DBMET02101 | DBMET02101 | |
| 0.158 | 0.041 | 0.315 | Cholesterol synthesis inhibitor | 0.186 0.03 DB01914 0.251 0.018 DB09526 0.223 0.022 DBMET02100 0.315 0.01 DBMET02101 | DBMET02101 | |
| 0.148 | 0.033 | 0.21 | TRPA1 agonist | 0.108 0.074 DB01914 0.21 0.009 DB09526 0.102 0.083 DBMET02100 0.192 0.012 DBMET02101 | DB09526 | |
| 0.131 | 0.018 | 0.136 | Interleukin 5 antagonist | 0.127 0.019 DB09526 0.136 0.015 DBMET02100 | DBMET02100 | |
| 0.223 | 0.113 | 0.518 | 5 Hydroxytryptamine uptake stimulant | 0.19 0.172 DB01914 0.518 0.004 DB09526 0.424 0.01 DBMET02100 0.262 0.07 DBMET02101 | DB09526 | |
| 0.185 | 0.075 | 0.185 | P-glycoprotein inhibitor | 0.176 0.084 DB09526 | ||
| 0.111 | 0.003 | 0.111 | Protein 30S ribosomal subunit inhibitor | |||
| 0.141 | 0.035 | 0.141 | Falcipain inhibitor | |||
| 0.139 | 0.034 | 0.139 | Falcipain 2 inhibitor | |||
| 0.105 | 0.002 | 0.105 | Uridine phosphorylase inhibitor | 0.051 0.008 DB01914 0.065 0.005 DB09526 0.034 0.015 DBMET02100 0.025 0.023 DBMET02101 | ||
| 0.148 | 0.048 | 0.164 | Antibacterial (Helicobacter pylori) | 0.164 0.036 DB09526 0.154 0.043 DBMET02101 | DB09526 | |
| 0.105 | 0.005 | 0.105 | Glucose-6-phosphate translocase inhibitor | 0.084 0.01 DB09526 0.061 0.023 DBMET02100 | ||
| 0.127 | 0.027 | 0.127 | Aminoacyl-tRNA synthetase inhibitor | 0.102 0.043 DB09526 0.088 0.062 DBMET02100 | ||
| 0.187 | 0.088 | 0.286 | Psychostimulant | 0.286 0.046 DB09526 | DB09526 | |
| 0.098 | 0.001 | 0.098 | Vanilloid 2 agonist | 0.046 0.003 DB09526 0.038 0.004 DBMET02100 0.043 0.004 DBMET02101 | ||
| 0.104 | 0.009 | 0.137 | Topoisomerase II beta inhibitor | 0.137 0.005 DB09526 0.056 0.025 DBMET02100 | DB09526 | |
| 0.117 | 0.024 | 0.231 | Glutamate dehydrogenase inhibitor | 0.165 0.014 DB01914 0.231 0.008 DB09526 0.142 0.017 DBMET02100 0.122 0.022 DBMET02101 | DB09526 | |
| 0.105 | 0.015 | 0.174 | Purinergic P2X1 antagonist | 0.07 0.032 DB01914 0.174 0.005 DB09526 0.103 0.016 DBMET02100 0.115 0.013 DBMET02101 | DB09526 | |
| 0.116 | 0.025 | 0.116 | Cell adhesion molecule inhibitor | |||
| 0.125 | 0.035 | 0.187 | Anabolic | 0.113 0.047 DB01914 0.175 0.008 DB09526 0.158 0.014 DBMET02100 0.187 0.006 DBMET02101 | DBMET02101 | |
| 0.159 | 0.07 | 0.543 | Diuretic | 0.149 0.079 DB01914 0.171 0.06 DB09526 0.543 0.006 DBMET02101 | DBMET02101 | |
| 0.09 | 0.005 | 0.09 | Arginase inhibitor | 0.062 0.01 DB09526 0.054 0.013 DBMET02100 | ||
| 0.1 | 0.015 | 0.214 | Neuraminidase inhibitor | 0.214 0.004 DB01914 0.092 0.018 DB09526 0.134 0.008 DBMET02100 0.141 0.007 DBMET02101 | DB01914 | |
| 0.09 | 0.005 | 0.168 | Adenine nucleotide translocase inhibitor | 0.093 0.005 DB09526 0.083 0.008 DBMET02100 0.168 0.003 DBMET02101 | DBMET02101 | |
| 0.092 | 0.007 | 0.092 | Phosphoglycerate kinase inhibitor | 0.054 0.013 DB01914 0.075 0.009 DB09526 0.031 0.03 DBMET02100 0.08 0.008 DBMET02101 | ||
| 0.103 | 0.019 | 0.174 | Glycine receptor agonist | 0.082 0.036 DB01914 0.174 0.005 DB09526 0.122 0.012 DBMET02100 0.091 0.027 DBMET02101 | DB09526 | |
| 0.135 | 0.052 | 0.148 | CC chemokine 6 receptor antagonist | 0.148 0.024 DB09526 | DB09526 | |
| 0.087 | 0.005 | 0.087 | Cytokine production stimulant | 0.059 0.014 DB09526 | ||
| 0.091 | 0.012 | 0.16 | Factor IXa inhibitor | 0.16 0.004 DBMET02101 | DBMET02101 | |
| 0.154 | 0.075 | 0.731 | Peroxidase inhibitor | 0.417 0.018 DB01914 0.731 0.003 DB09526 0.328 0.032 DBMET02100 0.578 0.005 DBMET02101 | DB09526 | |
| 0.085 | 0.008 | 0.099 | Adenosine deaminase inhibitor | 0.099 0.006 DB01914 0.07 0.014 DB09526 0.063 0.018 DBMET02100 0.058 0.022 DBMET02101 | DB01914 | |
| 0.09 | 0.013 | 0.519 | Estrogen receptor beta agonist | 0.509 0.003 DB09526 0.051 0.019 DBMET02100 0.519 0.003 DBMET02101 | DBMET02101 | |
| 0.079 | 0.003 | 0.079 | Ceramide glucosyltransferase inhibitor | 0.049 0.008 DB09526 0.046 0.009 DBMET02100 0.044 0.012 DBMET02101 | ||
| 0.164 | 0.089 | 0.442 | Succinate dehydrogenase inhibitor | 0.442 0.004 DB01914 0.414 0.004 DB09526 0.259 0.019 DBMET02100 0.276 0.015 DBMET02101 | DB01914 | |
| 0.077 | 0.003 | 0.077 | Guanylate cyclase inhibitor | 0.056 0.015 DB01914 0.072 0.004 DB09526 0.074 0.004 DBMET02100 0.071 0.005 DBMET02101 | ||
| 0.116 | 0.044 | 0.473 | Creatine kinase inhibitor | 0.133 0.032 DB01914 0.473 0.002 DB09526 0.214 0.009 DBMET02100 0.294 0.004 DBMET02101 | DB09526 | |
| 0.092 | 0.021 | 0.236 | Biliverdin reductase inhibitor | 0.236 0.004 DB01914 0.212 0.005 DB09526 0.11 0.016 DBMET02100 0.052 0.05 DBMET02101 | DB01914 | |
| 0.101 | 0.032 | 0.142 | Vanilloid agonist | 0.142 0.012 DB09526 0.1 0.033 DBMET02101 | DB09526 | |
| 0.07 | 0.003 | 0.07 | Ileal bile acid transport inhibitor | 0.019 0.01 DB01914 0.029 0.005 DB09526 | ||
| 0.085 | 0.018 | 0.085 | Nitric oxide donor | |||
| 0.126 | 0.059 | 0.404 | Protein-tyrosine phosphatase 1B inhibitor | 0.218 0.024 DB09526 0.135 0.053 DBMET02100 0.404 0.005 DBMET02101 | DBMET02101 | |
| 0.202 | 0.135 | 0.343 | Transcription factor STAT inhibitor | 0.343 0.037 DB09526 | DB09526 | |
| 0.089 | 0.022 | 0.187 | Argininosuccinate synthase inhibitor | 0.156 0.011 DB01914 0.187 0.008 DB09526 0.107 0.018 DBMET02100 | DB09526 | |
| 0.067 | 0.001 | 0.067 | Telomerase stimulant | 0.016 0.015 DB01914 0.03 0.003 DB09526 0.021 0.006 DBMET02100 | ||
| 0.075 | 0.009 | 0.075 | Factor III inhibitor | 0.07 0.01 DB09526 0.049 0.037 DBMET02100 | ||
| 0.095 | 0.03 | 0.109 | Lipase inhibitor | 0.109 0.023 DB09526 | DB09526 | |
| 0.084 | 0.019 | 0.084 | Antimetabolite | 0.047 0.033 DB09526 | ||
| 0.088 | 0.024 | 0.108 | Carbonic anhydrase IX inhibitor | 0.07 0.032 DB09526 0.108 0.018 DBMET02101 | DBMET02101 | |
| 0.093 | 0.029 | 0.645 | HIV-1 integrase (3'-Processing) inhibitor | 0.282 0.005 DB09526 0.103 0.025 DBMET02100 0.645 0.003 DBMET02101 | DBMET02101 | |
| 0.146 | 0.083 | 0.598 | Protein-tyrosine phosphatase inhibitor | 0.274 0.025 DB09526 0.146 0.082 DBMET02100 0.598 0.004 DBMET02101 | DBMET02101 | |
| 0.136 | 0.073 | 0.136 | Neurotrophic factor | 0.119 0.096 DB01914 0.113 0.108 DB09526 | ||
| 0.117 | 0.057 | 0.44 | Chelator | 0.349 0.008 DB01914 0.44 0.005 DB09526 0.098 0.08 DBMET02100 | DB09526 | |
| 0.074 | 0.014 | 0.081 | Carbonic anhydrase VII inhibitor | 0.081 0.013 DB09526 0.053 0.025 DBMET02101 | DB09526 | |
| 0.072 | 0.013 | 0.101 | Squalene epoxidase inhibitor | 0.101 0.005 DB09526 | DB09526 | |
| 0.082 | 0.024 | 0.893 | Alcohol oxidase inhibitor | 0.893 0.002 DB01914 0.885 0.002 DB09526 0.434 0.004 DBMET02100 0.136 0.012 DBMET02101 | DB01914 | |
| 0.086 | 0.028 | 0.532 | HIV-1 integrase (Strand Transfer) inhibitor | 0.252 0.006 DB09526 0.094 0.025 DBMET02100 0.532 0.003 DBMET02101 | DBMET02101 | |
| 0.229 | 0.173 | 0.444 | Calcium channel activator | 0.444 0.012 DB09526 0.369 0.038 DBMET02100 0.292 0.1 DBMET02101 | DB09526 | |
| 0.079 | 0.023 | 0.183 | Acyl-CoA dehydrogenase inhibitor | 0.162 0.008 DB01914 0.183 0.006 DB09526 0.103 0.016 DBMET02100 0.047 0.046 DBMET02101 | DB09526 | |
| 0.195 | 0.14 | 0.323 | Transcription factor STAT3 inhibitor | 0.323 0.043 DB09526 | DB09526 | |
| 0.104 | 0.05 | 0.166 | Lanosterol 14 alpha demethylase inhibitor | 0.166 0.007 DB09526 | DB09526 | |
| 0.068 | 0.014 | 0.435 | Estrogen receptor alpha agonist | 0.435 0.003 DB09526 0.046 0.018 DBMET02100 0.143 0.005 DBMET02101 | DB09526 | |
| 0.065 | 0.012 | 0.065 | Thymidine kinase inhibitor | 0.045 0.023 DB01914 0.055 0.016 DB09526 0.054 0.016 DBMET02101 | ||
| 0.073 | 0.023 | 0.105 | Fatty acid synthase inhibitor | 0.105 0.01 DB09526 0.059 0.037 DBMET02100 | DB09526 | |
| 0.07 | 0.022 | 0.07 | Lipocortins synthesis agonist | 0.066 0.026 DB09526 0.066 0.026 DBMET02100 | ||
| 0.066 | 0.019 | 0.066 | Toll-Like receptor 2 agonist | 0.052 0.023 DB01914 0.044 0.027 DB09526 | ||
| 0.079 | 0.032 | 0.102 | Protein kinase C beta inhibitor | 0.102 0.013 DB09526 | DB09526 | |
| 0.048 | 0.002 | 0.048 | Antibiotic Anthracycline-like | 0.018 0.016 DB01914 0.033 0.003 DB09526 0.022 0.008 DBMET02100 0.018 0.015 DBMET02101 | ||
| 0.047 | 0.004 | 0.049 | Toll-Like receptor 4 agonist | 0.049 0.004 DBMET02101 | DBMET02101 | |
| 0.192 | 0.15 | 0.652 | Tyrosine 3 hydroxylase inhibitor | 0.226 0.095 DB01914 0.652 0.003 DB09526 0.288 0.04 DBMET02100 0.331 0.021 DBMET02101 | DB09526 | |
| 0.122 | 0.081 | 0.291 | NADPH oxidase inhibitor | 0.291 0.014 DB09526 | DB09526 | |
| 0.069 | 0.029 | 0.098 | Protein kinase C eta inhibitor | 0.098 0.018 DB09526 | DB09526 | |
| 0.048 | 0.009 | 0.072 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.072 0.005 DB01914 0.043 0.011 DB09526 | DB01914 | |
| 0.091 | 0.054 | 0.137 | Ornithine decarboxylase inhibitor | 0.112 0.032 DB01914 0.137 0.016 DB09526 0.099 0.046 DBMET02100 | DB09526 | |
| 0.08 | 0.043 | 0.085 | Adenosine A3 receptor antagonist | 0.085 0.037 DB09526 | DB09526 | |
| 0.05 | 0.014 | 0.105 | Fumarate hydratase inhibitor | 0.068 0.009 DB01914 0.105 0.005 DB09526 0.057 0.011 DBMET02100 | DB09526 | |
| 0.095 | 0.06 | 0.138 | Bile acid receptor antagonist | 0.132 0.012 DB09526 0.138 0.01 DBMET02100 0.138 0.01 DBMET02101 | DBMET02101 | |
| 0.12 | 0.085 | 0.141 | Toll-Like receptor antagonist | 0.141 0.062 DB09526 | DB09526 | |
| 0.039 | 0.004 | 0.075 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 DB09526 0.032 0.011 DBMET02100 0.075 0.002 DBMET02101 | DBMET02101 | |
| 0.042 | 0.007 | 0.042 | Adenosine A1 receptor agonist | |||
| 0.073 | 0.038 | 0.258 | Carbonic anhydrase inhibitor | 0.084 0.033 DB09526 0.258 0.005 DBMET02101 | DBMET02101 | |
| 0.061 | 0.027 | 0.085 | Leukotriene B4 antagonist | 0.066 0.022 DB09526 0.058 0.031 DBMET02100 0.085 0.014 DBMET02101 | DBMET02101 | |
| 0.078 | 0.044 | 0.413 | Histidine decarboxylase inhibitor | 0.122 0.025 DB01914 0.413 0.004 DB09526 0.165 0.017 DBMET02100 0.074 0.047 DBMET02101 | DB09526 | |
| 0.085 | 0.053 | 0.134 | Glutathione S-transferase inhibitor | 0.076 0.069 DB01914 0.134 0.017 DB09526 | DB09526 | |
| 0.065 | 0.035 | 0.126 | Xanthine dehydrogenase inhibitor | 0.126 0.01 DB09526 0.068 0.032 DBMET02100 | DB09526 | |
| 0.051 | 0.022 | 0.098 | Neuraminidase (Influenza A) inhibitor | 0.098 0.004 DB01914 0.045 0.033 DB09526 0.079 0.005 DBMET02100 | DB01914 | |
| 0.159 | 0.131 | 0.875 | Aldehyde oxidase inhibitor | 0.655 0.012 DB01914 0.875 0.004 DB09526 0.513 0.031 DBMET02100 0.451 0.04 DBMET02101 | DB09526 | |
| 0.083 | 0.055 | 0.108 | Thioredoxin reductase inhibitor | 0.108 0.023 DB09526 | DB09526 | |
| 0.035 | 0.007 | 0.035 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 DB01914 0.032 0.009 DB09526 0.03 0.011 DBMET02101 | ||
| 0.101 | 0.074 | 0.175 | Protein kinase C gamma inhibitor | 0.175 0.02 DB09526 | DB09526 | |
| 0.034 | 0.009 | 0.034 | Thymidine phosphorylase inhibitor | 0.033 0.009 DB09526 | ||
| 0.051 | 0.026 | 0.051 | Microtubule stabilization | 0.051 0.026 DB01914 | ||
| 0.038 | 0.015 | 0.038 | Adenosine uptake inhibitor | 0.035 0.024 DB09526 | ||
| 0.029 | 0.006 | 0.032 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 DB01914 0.03 0.005 DB09526 0.032 0.004 DBMET02100 | DBMET02100 | |
| 0.031 | 0.008 | 0.073 | Dopamine D1 agonist | 0.051 0.005 DB09526 0.073 0.004 DBMET02101 | DBMET02101 | |
| 0.032 | 0.009 | 0.032 | Motilin receptor agonist | |||
| 0.037 | 0.014 | 0.037 | Protein kinase C beta I inhibitor | 0.037 0.013 DB09526 | ||
| 0.061 | 0.04 | 0.074 | Prostaglandin EP2 antagonist | 0.074 0.03 DBMET02100 | DBMET02100 | |
| 0.056 | 0.037 | 0.131 | Maillard reaction inhibitor | 0.104 0.015 DB01914 0.131 0.008 DB09526 | DB09526 | |
| 0.094 | 0.076 | 0.705 | Estrogen receptor beta antagonist | 0.705 0.003 DB09526 0.124 0.028 DBMET02100 0.224 0.008 DBMET02101 | DB09526 | |
| 0.036 | 0.019 | 0.036 | Melatonin 2 agonist | |||
| 0.101 | 0.083 | 0.116 | Nav1.5 sodium channel blocker | 0.116 0.06 DB09526 | DB09526 | |
| 0.022 | 0.006 | 0.097 | Antibiotic Macrolide-like | 0.097 0.003 DBMET02100 | DBMET02100 | |
| 0.081 | 0.064 | 0.19 | Estrogen-related receptor beta agonist | 0.087 0.046 DB01914 0.19 0.003 DB09526 0.104 0.02 DBMET02100 0.101 0.024 DBMET02101 | DB09526 | |
| 0.018 | 0.002 | 0.018 | Purinergic P2Y2 agonist | 0.01 0.007 DB09526 | ||
| 0.054 | 0.04 | 0.084 | Ribonucleotide reductase inhibitor | 0.084 0.025 DB01914 0.079 0.027 DB09526 | DB01914 | |
| 0.052 | 0.038 | 0.207 | Ornithine carbamoyltransferase inhibitor | 0.207 0.007 DB01914 0.105 0.015 DB09526 0.057 0.034 DBMET02100 0.053 0.037 DBMET02101 | DB01914 | |
| 0.105 | 0.092 | 0.175 | Transcription factor STAT6 inhibitor | 0.175 0.011 DB09526 | DB09526 | |
| 0.02 | 0.007 | 0.02 | O6-alkylguanine-DNA alkyltransferase inhibitor | |||
| 0.023 | 0.012 | 0.023 | Inosine monophosphate dehydrogenase 1 inhibitor | |||
| 0.097 | 0.085 | 0.208 | Interleukin 1b antagonist | 0.208 0.018 DB01914 | DB01914 | |
| 0.071 | 0.06 | 0.213 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.099 0.038 DB01914 0.213 0.008 DB09526 0.085 0.047 DBMET02100 0.102 0.036 DBMET02101 | DB09526 | |
| 0.018 | 0.008 | 0.018 | Purinergic P2 agonist | |||
| 0.018 | 0.008 | 0.018 | Purinergic receptor agonist | |||
| 0.018 | 0.008 | 0.021 | Purinergic P2Y1 agonist | 0.021 0.006 DB09526 0.019 0.007 DBMET02101 | DB09526 | |
| 0.095 | 0.086 | 0.287 | DOPA decarboxylase inhibitor | 0.116 0.05 DB01914 0.287 0.003 DB09526 0.17 0.013 DBMET02100 0.149 0.022 DBMET02101 | DB09526 | |
| 0.051 | 0.043 | 0.121 | Carbonic anhydrase II inhibitor | 0.067 0.031 DB09526 0.121 0.014 DBMET02101 | DBMET02101 | |
| 0.018 | 0.009 | 0.018 | Adenosine A2 receptor agonist | 0.016 0.012 DB01914 0.017 0.01 DB09526 | ||
| 0.074 | 0.066 | 0.136 | MAP kinase kinase 7 inhibitor | 0.136 0.003 DB09526 0.098 0.014 DBMET02100 0.082 0.041 DBMET02101 | DB09526 | |
| 0.016 | 0.01 | 0.017 | Adenosine A2a receptor agonist | 0.017 0.009 DB09526 | DB09526 | |
| 0.058 | 0.051 | 0.058 | DNA gyrase inhibitor | |||
| 0.014 | 0.007 | 0.014 | Purinergic P2Y agonist | |||
| 0.048 | 0.042 | 0.083 | Ribonucleoside-diphosphate reductase inhibitor | 0.083 0.024 DB01914 0.077 0.026 DB09526 | DB01914 | |
| 0.017 | 0.012 | 0.017 | Adenosine A3 receptor agonist | |||
| 0.051 | 0.046 | 0.112 | Sphingosine kinase 2 inhibitor | 0.053 0.042 DB01914 0.112 0.005 DB09526 | DB09526 | |
| 0.015 | 0.01 | 0.235 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.235 0.002 DB01914 0.015 0.01 DBMET02100 | DB01914 | |
| 0.014 | 0.01 | 0.014 | Adenosine A2b receptor agonist | |||
| 0.024 | 0.021 | 0.024 | Purinergic P2X agonist | 0.023 0.022 DBMET02101 | ||
| 0.019 | 0.017 | 0.019 | Adenosine kinase inhibitor | |||
| 0.003 | 0.002 | 0.003 | Purinergic P2Y6 agonist | |||
| 0.019 | 0.018 | 0.019 | Corticosteroid-like | |||
| 0.047 | 0.046 | 0.128 | Carbonic anhydrase I inhibitor | 0.063 0.033 DB09526 0.128 0.013 DBMET02101 | DBMET02101 | |
| 0.054 | 0.053 | 0.142 | Sphingosine kinase inhibitor | 0.084 0.013 DB01914 0.096 0.009 DB09526 0.142 0.004 DBMET02101 | DBMET02101 | |
| 0.017 | 0.017 | 0.027 | Methylmalonyl-CoA mutase inhibitor | 0.027 0.003 DB01914 0.022 0.005 DB09526 0.019 0.01 DBMET02100 | DB01914 | |
| 0.065 | 0.067 | 0.313 | CDC25A inhibitor | 0.131 0.016 DB09526 0.313 0.004 DBMET02101 | DBMET02101 | |
| 0.019 | 0.022 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.015 DB01914 0.027 0.005 DB09526 | DB09526 | |
| 0.086 | 0.091 | 0.332 | Carbonic anhydrase XV inhibitor | 0.332 0.006 DB09526 0.113 0.052 DBMET02100 0.229 0.014 DBMET02101 | DB09526 | |
| 0.022 | 0.027 | 0.07 | Thyroid hormone agonist | 0.052 0.004 DB09526 0.07 0.003 DBMET02101 | DBMET02101 | |
| 0.041 | 0.046 | 0.062 | Cholesterol esterase inhibitor | 0.062 0.015 DB09526 0.043 0.042 DBMET02100 | DB09526 | |
| 0.05 | 0.056 | 0.118 | Androgen agonist | 0.118 0.01 DB09526 0.054 0.05 DBMET02100 0.107 0.012 DBMET02101 | DB09526 | |
| 0.058 | 0.064 | 0.332 | Carbonic anhydrase VA inhibitor | 0.153 0.01 DB09526 0.332 0.003 DBMET02101 | DBMET02101 | |
| 0.057 | 0.063 | 0.084 | Beta 2 adrenoreceptor agonist | 0.084 0.007 DB09526 0.059 0.055 DBMET02100 0.064 0.034 DBMET02101 | DB09526 | |
| 0.108 | 0.116 | 0.205 | Cytidine deaminase inhibitor | 0.205 0.046 DB09526 | DB09526 | |
| 0.094 | 0.102 | 0.178 | Acetylcholine release stimulant | 0.149 0.017 DB09526 0.178 0.006 DBMET02101 | DBMET02101 | |
| 0.145 | 0.153 | 0.265 | Growth factor agonist | 0.265 0.025 DB01914 | DB01914 | |
| 0.056 | 0.064 | 0.411 | Phenylalanine 4-hydroxylase inhibitor | 0.246 0.005 DB01914 0.411 0.003 DB09526 0.105 0.023 DBMET02100 0.194 0.007 DBMET02101 | DB09526 | |
| 0.018 | 0.027 | 0.045 | Prostaglandin F2 alpha agonist | 0.03 0.009 DB01914 0.045 0.005 DB09526 0.033 0.008 DBMET02100 | DB09526 | |
| 0.028 | 0.037 | 0.146 | Estrogen-related receptor beta antagonist | 0.146 0.002 DB09526 0.036 0.015 DBMET02101 | DB09526 | |
| 0.029 | 0.038 | 0.042 | Inosine monophosphate dehydrogenase inhibitor | 0.042 0.02 DB09526 | DB09526 | |
| 0.008 | 0.019 | 0.014 | Purine nucleoside phosphorylase inhibitor | 0.014 0.005 DB01914 0.012 0.008 DB09526 | DB01914 | |
| 0.029 | 0.041 | 0.039 | Tubulin agonist | 0.039 0.017 DB09526 0.034 0.024 DBMET02100 | DB09526 | |
| 0.035 | 0.048 | 0.063 | CF transmembrane conductance regulator antagonist | 0.063 0.004 DB09526 | DB09526 | |
| 0.027 | 0.041 | 0.061 | Glutamate (mGluR3) agonist | 0.061 0.004 DB09526 0.057 0.004 DBMET02100 | DB09526 | |
| 0.036 | 0.05 | 0.068 | AICAR transformylase inhibitor | 0.04 0.037 DB01914 0.068 0.01 DB09526 0.06 0.014 DBMET02101 | DB09526 | |
| 0.023 | 0.038 | 0.045 | Purinergic P2Y15 antagonist | 0.045 0.005 DB09526 | DB09526 | |
| 0.133 | 0.149 | 0.255 | Neurotensin receptor agonist | 0.255 0.02 DB09526 0.153 0.094 DBMET02100 0.16 0.08 DBMET02101 | DB09526 | |
| 0.002 | 0.018 | 0.008 | Transcortin receptor antagonist | 0.008 0.003 DB09526 | DB09526 | |
| 0.051 | 0.068 | 0.502 | Carbonic anhydrase V inhibitor | 0.171 0.01 DB09526 0.502 0.002 DBMET02101 | DBMET02101 | |
| 0.06 | 0.078 | 0.117 | Phospholipase D inhibitor | 0.111 0.009 DB09526 0.117 0.007 DBMET02101 | DBMET02101 | |
| 0.091 | 0.111 | 0.246 | Cyclooxygenase 1 inhibitor | 0.246 0.022 DB09526 0.225 0.026 DBMET02101 | DB09526 | |
| 0.033 | 0.053 | 0.058 | Sphingosine kinase 1 inhibitor | 0.042 0.027 DB01914 0.058 0.01 DB09526 | DB09526 | |
| 0.012 | 0.032 | 0.017 | Vitamin D receptor agonist | 0.016 0.013 DB01914 0.017 0.01 DB09526 | DB09526 | |
| 0.039 | 0.062 | 0.059 | Prolyl endopeptidase inhibitor | 0.059 0.025 DB09526 | DB09526 | |
| 0.076 | 0.1 | 0.277 | Protein kinase C zeta inhibitor | 0.162 0.017 DB09526 0.277 0.006 DBMET02101 | DBMET02101 | |
| 0.038 | 0.064 | 0.059 | Adenosine A1 receptor antagonist | 0.059 0.04 DB09526 | DB09526 | |
| 0.061 | 0.088 | 0.275 | Keratolytic | 0.115 0.023 DB01914 0.275 0.004 DB09526 0.142 0.016 DBMET02100 0.075 0.057 DBMET02101 | DB09526 | |
| 0.04 | 0.068 | 0.215 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.078 0.017 DB01914 0.215 0.004 DB09526 0.064 0.026 DBMET02100 0.164 0.005 DBMET02101 | DB09526 | |
| 0.021 | 0.052 | 0.071 | ATP citrate lysase inhibitor | 0.071 0.004 DB09526 0.041 0.012 DBMET02100 | DB09526 | |
| 0.017 | 0.047 | 0.02 | Vitamin D receptor antagonist | 0.02 0.019 DB01914 | DB01914 | |
| 0.048 | 0.078 | 0.118 | CDC25B inhibitor | 0.118 0.011 DB09526 | DB09526 | |
| 0.024 | 0.057 | 0.037 | Protein kinase C beta II inhibitor | 0.037 0.014 DB09526 | DB09526 | |
| 0.074 | 0.107 | 0.138 | Interleukin 1 beta converting enzyme inhibitor | 0.138 0.023 DB09526 | DB09526 | |
| 0.011 | 0.047 | 0.018 | Antibiotic Tetracycline-like | 0.018 0.005 DB09526 | DB09526 | |
| 0.055 | 0.09 | 0.129 | Glutamate (mGluR6) antagonist | 0.076 0.03 DB01914 0.119 0.006 DB09526 0.129 0.005 DBMET02100 | DBMET02100 | |
| 0.051 | 0.087 | 0.332 | Glutamate decarboxylase inhibitor | 0.264 0.004 DB01914 0.332 0.003 DB09526 0.135 0.016 DBMET02100 0.173 0.009 DBMET02101 | DB09526 | |
| 0.044 | 0.082 | 0.081 | Leukotriene antagonist | 0.081 0.031 DB09526 0.061 0.05 DBMET02100 0.067 0.043 DBMET02101 | DB09526 | |
| 0.009 | 0.049 | 0.046 | Prostaglandin EP2 agonist | 0.046 0.007 DB01914 0.03 0.012 DB09526 0.023 0.016 DBMET02100 | DB01914 | |
| 0.057 | 0.097 | 0.262 | Macrophage migration inhibitory factor inhibitor | 0.262 0.005 DB09526 0.143 0.017 DBMET02100 0.128 0.022 DBMET02101 | DB09526 | |
| 0.06 | 0.102 | 0.222 | Potassium channel (Ca-activated) activator | 0.222 0.011 DB09526 | DB09526 | |
| 0.004 | 0.047 | 0.025 | Glutamate (mGluR6) agonist | 0.025 0.004 DB09526 0.021 0.004 DBMET02100 | DB09526 | |
| 0.052 | 0.096 | 0.233 | HIV-1 integrase inhibitor | 0.186 0.005 DB09526 0.233 0.004 DBMET02101 | DBMET02101 | |
| 0.013 | 0.059 | 0.03 | Neuraminidase (Influenza B) inhibitor | 0.024 0.009 DB01914 0.03 0.004 DB09526 0.029 0.005 DBMET02100 | DB09526 | |
| 0.005 | 0.051 | 0.025 | Lysophosphatidic acid receptor 3 agonist | 0.025 0.004 DB01914 0.018 0.006 DB09526 | DB01914 | |
| 0.046 | 0.094 | 0.573 | Porphobilinogen synthase inhibitor | 0.096 0.038 DB01914 0.573 0.003 DB09526 0.113 0.031 DBMET02100 0.265 0.007 DBMET02101 | DB09526 | |
| 0.046 | 0.096 | 0.093 | Aryl hydrocarbon receptor antagonist | 0.093 0.017 DB09526 | DB09526 | |
| 0.031 | 0.084 | 0.049 | DNA gyrase subunit A inhibitor | 0.049 0.018 DB09526 | DB09526 | |
| 0.004 | 0.058 | 0.013 | Thromboxane agonist | 0.01 0.009 DB01914 0.013 0.005 DB09526 0.011 0.008 DBMET02100 | DB09526 | |
| 0.002 | 0.057 | 0.422 | Mannitol 2-dehydrogenase inhibitor | 0.422 0 DB01914 | DB01914 | |
| 0.026 | 0.081 | 0.081 | Glutamate (mGluR8) agonist | 0.039 0.023 DB01914 0.081 0.004 DB09526 0.063 0.006 DBMET02100 | DB09526 | |
| 0.02 | 0.078 | 0.379 | Dopamine D2 agonist | 0.112 0.009 DB09526 0.379 0.004 DBMET02101 | DBMET02101 | |
| 0.107 | 0.166 | 0.38 | Pyruvate kinase inhibitor | 0.36 0.03 DB01914 0.38 0.025 DB09526 | DB09526 | |
| 0.024 | 0.084 | 0.315 | Carbonic anhydrase VB inhibitor | 0.177 0.006 DB09526 0.315 0.003 DBMET02101 | DBMET02101 | |
| 0.066 | 0.126 | 0.584 | GABA C receptor agonist | 0.197 0.021 DB01914 0.584 0.003 DB09526 0.38 0.005 DBMET02100 0.192 0.022 DBMET02101 | DB09526 | |
| 0.057 | 0.118 | 0.177 | Estrogen receptor alpha antagonist | 0.177 0.009 DB09526 0.091 0.034 DBMET02100 0.083 0.044 DBMET02101 | DB09526 | |
| 0.021 | 0.083 | 0.213 | Dopamine D5 agonist | 0.213 0.002 DB09526 0.038 0.031 DBMET02100 0.067 0.009 DBMET02101 | DB09526 | |
| 0.007 | 0.072 | 0.022 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.022 0.012 DB09526 | DB09526 | |
| 0.094 | 0.159 | 0.196 | Phospholipase A2 inhibitor | 0.134 0.095 DB01914 0.196 0.044 DB09526 0.149 0.075 DBMET02101 | DB09526 | |
| 0.065 | 0.132 | 0.172 | Granulocyte macrophage colony stimulating factor agonist | 0.088 0.056 DB01914 0.172 0.004 DB09526 0.084 0.065 DBMET02101 | DB09526 | |
| 0.018 | 0.085 | 0.063 | Estrogen-related receptor gamma antagonist | 0.063 0.002 DB09526 0.042 0.005 DBMET02101 | DB09526 | |
| 0.019 | 0.086 | 0.057 | Purinergic P2Y antagonist | 0.048 0.028 DB09526 0.057 0.021 DBMET02100 | DBMET02100 | |
| 0.004 | 0.071 | 0.013 | Prostaglandin EP4 agonist | 0.013 0.012 DB09526 | DB09526 | |
| 0.012 | 0.083 | 0.039 | Prostaglandin agonist | 0.037 0.015 DB01914 0.037 0.016 DB09526 0.039 0.014 DBMET02100 | DBMET02100 | |
| 0.017 | 0.088 | 0.114 | Factor Xa inhibitor | 0.114 0.011 DBMET02101 | DBMET02101 | |
| 0.087 | 0.159 | 0.123 | Interleukin 1 antagonist | 0.123 0.084 DB01914 0.113 0.099 DB09526 | DB01914 | |
| 0.029 | 0.101 | 0.056 | Adenosine A2a receptor antagonist | 0.056 0.049 DB09526 | DB09526 | |
| 0.044 | 0.12 | 0.218 | Potassium channel large-conductance Ca-activated activator | 0.218 0.005 DB09526 | DB09526 | |
| 0.002 | 0.078 | 0.007 | Insulin like growth factor 3 antagonist | 0.007 0.004 DB09526 | DB09526 | |
| 0.006 | 0.084 | 0.088 | Purinergic P2T antagonist | 0.088 0.005 DBMET02100 | DBMET02100 | |
| 0.047 | 0.127 | 0.126 | Somatostatin 1 agonist | 0.126 0.021 DB09526 | DB09526 | |
| 0.006 | 0.088 | 0.025 | Prostaglandin E2 agonist | 0.025 0.014 DB01914 0.025 0.014 DB09526 0.024 0.015 DBMET02100 | DB09526 | |
| 0.011 | 0.095 | 0.046 | HCV NS5B polymerase inhibitor | 0.046 0.011 DB09526 0.03 0.023 DBMET02100 | DB09526 | |
| 0.034 | 0.119 | 0.081 | Epithelial sodium channel blocker | 0.072 0.017 DB01914 0.081 0.012 DB09526 | DB09526 | |
| 0.019 | 0.103 | 0.109 | Purinergic P2Y2 antagonist | 0.109 0.004 DBMET02101 | DBMET02101 | |
| 0.04 | 0.127 | 0.162 | Aminopeptidase I inhibitor | 0.139 0.015 DB01914 0.162 0.011 DB09526 0.091 0.033 DBMET02100 0.07 0.053 DBMET02101 | DB09526 | |
| 0.026 | 0.114 | 0.112 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.112 0.002 DB09526 0.051 0.014 DBMET02100 0.068 0.005 DBMET02101 | DB09526 | |
| 0.018 | 0.106 | 0.041 | Hedgehog signaling activator | 0.041 0.004 DB09526 | DB09526 | |
| 0.029 | 0.117 | 0.171 | Aconitate hydratase inhibitor | 0.12 0.006 DB01914 0.171 0.004 DB09526 0.122 0.005 DBMET02100 0.052 0.035 DBMET02101 | DB09526 | |
| 0.012 | 0.101 | 0.047 | 5-Alpha-reductase inhibitor | 0.047 0.02 DB09526 0.045 0.021 DBMET02100 | DB09526 | |
| 0.018 | 0.107 | 0.073 | HIV-1 protease inhibitor | 0.073 0.007 DB01914 | DB01914 | |
| 0.053 | 0.144 | 0.247 | HIV-1 integrase (Overall Integration) inhibitor | 0.247 0.005 DB09526 0.159 0.022 DBMET02100 0.171 0.019 DBMET02101 | DB09526 | |
| 0.006 | 0.097 | 0.023 | Thromboxane A2 agonist | 0.019 0.006 DB01914 0.023 0.004 DB09526 | DB09526 | |
| 0.011 | 0.103 | 0.035 | Prostaglandin D2 agonist | 0.035 0.016 DBMET02100 | DBMET02100 | |
| 0.049 | 0.141 | 0.25 | Aminopeptidase B inhibitor | 0.207 0.02 DB01914 0.216 0.018 DB09526 0.126 0.049 DBMET02100 0.25 0.013 DBMET02101 | DBMET02101 | |
| 0.026 | 0.12 | 0.075 | Kainate receptor agonist | 0.075 0.004 DB09526 0.053 0.011 DBMET02100 | DB09526 | |
| 0.031 | 0.126 | 0.059 | Beta adrenoreceptor agonist | 0.059 0.009 DB09526 | DB09526 | |
| 0.008 | 0.104 | 0.032 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.032 0.015 DB09526 | DB09526 | |
| 0.018 | 0.116 | 0.158 | Opioid mu receptor agonist | 0.158 0.006 DB09526 | DB09526 | |
| 0.041 | 0.139 | 0.072 | Leukotriene C antagonist | 0.072 0.013 DB09526 0.055 0.044 DBMET02100 | DB09526 | |
| 0.073 | 0.173 | 0.177 | Cyclooxygenase inhibitor | 0.177 0.052 DB09526 | DB09526 | |
| 0.009 | 0.109 | 0.024 | Leukotriene B4 receptor 2 antagonist | 0.024 0.013 DB09526 | DB09526 | |
| 0.061 | 0.163 | 0.194 | D-Ala-D-Ala ligase inhibitor | 0.194 0.004 DB09526 0.088 0.047 DBMET02100 0.095 0.035 DBMET02101 | DB09526 | |
| 0.011 | 0.113 | 0.055 | Carbonic anhydrase IV inhibitor | 0.055 0.022 DB09526 | DB09526 | |
| 0.088 | 0.191 | 0.277 | Farnesoid X receptor antagonist | 0.277 0.008 DB09526 0.165 0.038 DBMET02100 0.121 0.102 DBMET02101 | DB09526 | |
| 0.007 | 0.11 | 0.039 | Squalene synthetase inhibitor | 0.039 0.019 DBMET02100 | DBMET02100 | |
| 0.038 | 0.141 | 0.086 | Protease 3C (Human rhinovirus) inhibitor | 0.069 0.038 DB01914 0.086 0.023 DB09526 0.083 0.025 DBMET02101 | DB09526 | |
| 0.042 | 0.145 | 0.11 | Ryanodine receptor antagonist | 0.11 0.004 DB09526 0.067 0.021 DBMET02100 | DB09526 | |
| 0.007 | 0.111 | 0.089 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.089 0.004 DB09526 0.023 0.015 DBMET02101 | DB09526 | |
| 0.161 | 0.267 | 0.699 | GABA C receptor rho-3 antagonist | 0.265 0.141 DB01914 0.699 0.003 DB09526 0.306 0.112 DBMET02100 0.442 0.045 DBMET02101 | DB09526 | |
| 0.026 | 0.132 | 0.048 | Leukotriene C4 antagonist | 0.048 0.012 DB09526 | DB09526 | |
| 0.086 | 0.196 | 0.253 | Heat shock protein 90 antagonist | 0.253 0.02 DB09526 0.16 0.065 DBMET02100 | DB09526 | |
| 0.019 | 0.129 | 0.064 | Liver X receptor alpha agonist | 0.064 0.011 DB09526 | DB09526 | |
| 0.023 | 0.133 | 0.074 | Lysophosphatidic acid 3 receptor antagonist | 0.056 0.027 DB01914 0.074 0.012 DB09526 | DB09526 | |
| 0.017 | 0.128 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.037 0.026 DB09526 | DB09526 | |
| 0.009 | 0.121 | 0.028 | Beta 1 adrenoreceptor agonist | 0.028 0.009 DB09526 | DB09526 | |
| 0.008 | 0.12 | 0.02 | Purinergic P2Y12 antagonist | 0.02 0.019 DBMET02100 | DBMET02100 | |
| 0.012 | 0.127 | 0.084 | Opioid delta receptor agonist | 0.084 0.006 DB09526 | DB09526 | |
| 0.018 | 0.134 | 0.063 | Thymidylate synthase inhibitor | 0.048 0.031 DB01914 0.063 0.015 DB09526 | DB09526 | |
| 0.03 | 0.146 | 0.268 | Catalase inhibitor | 0.268 0.007 DB01914 0.208 0.014 DB09526 0.239 0.01 DBMET02101 | DB01914 | |
| 0.029 | 0.147 | 0.126 | Leukotriene synthesis inhibitor | 0.126 0.015 DB09526 | DB09526 | |
| 0.025 | 0.144 | 0.078 | Purinergic P2X4 antagonist | 0.078 0.007 DB09526 | DB09526 | |
| 0.062 | 0.181 | 0.147 | Caspase 3 inhibitor | 0.107 0.081 DB01914 0.147 0.03 DB09526 | DB09526 | |
| 0.04 | 0.16 | 0.083 | Metalloproteinase-9 inhibitor | 0.083 0.042 DB09526 | DB09526 | |
| 0.049 | 0.17 | 0.105 | Vanilloid 4 agonist | 0.071 0.063 DB01914 0.105 0.014 DB09526 | DB09526 | |
| 0.073 | 0.194 | 0.187 | Interleukin 8 antagonist | 0.187 0.017 DB09526 | DB09526 | |
| 0.06 | 0.184 | 0.261 | Bone formation stimulant | 0.261 0.023 DB09526 | DB09526 | |
| 0.008 | 0.133 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.013 DB09526 0.017 0.016 DBMET02100 | DB09526 | |
| 0.016 | 0.141 | 0.051 | RNA-directed RNA polymerase inhibitor | 0.051 0.012 DB09526 0.037 0.021 DBMET02100 | DB09526 | |
| 0.008 | 0.134 | 0.039 | Estrogen-related receptor gamma agonist | 0.039 0.003 DB09526 | DB09526 | |
| 0.002 | 0.13 | 0.014 | Thyroid hormone beta agonist | 0.014 0.004 DB09526 | DB09526 | |
| 0.004 | 0.134 | 0.032 | NMDA receptor phencyclidine site antagonist | 0.032 0.004 DB09526 | DB09526 | |
| 0.047 | 0.178 | 0.259 | Prolactin inhibitor | 0.097 0.059 DB01914 0.259 0.004 DB09526 0.09 0.067 DBMET02100 0.1 0.055 DBMET02101 | DB09526 | |
| 0.003 | 0.134 | 0.015 | G-protein-coupled receptor 120 agonist | 0.015 0.014 DB09526 | DB09526 | |
| 0.023 | 0.154 | 0.107 | Purinergic P2X2 antagonist | 0.107 0.027 DB09526 0.057 0.054 DBMET02101 | DB09526 | |
| 0.014 | 0.147 | 0.069 | Oxytocin agonist | 0.069 0.01 DB09526 0.042 0.029 DBMET02101 | DB09526 | |
| 0.009 | 0.143 | 0.289 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.289 0.003 DB09526 0.066 0.009 DBMET02101 | DB09526 | |
| 0.015 | 0.151 | 0.079 | Glutamate (mGluR3) antagonist | 0.071 0.006 DB09526 0.079 0.005 DBMET02100 | DBMET02100 | |
| 0.007 | 0.147 | 0.044 | Kynurenine 3 monooxygenase inhibitor | 0.031 0.015 DB09526 0.026 0.019 DBMET02100 0.044 0.008 DBMET02101 | DBMET02101 | |
| 0.006 | 0.147 | 0.022 | Thyroid hormone alpha agonist | 0.022 0.005 DB09526 | DB09526 | |
| 0.01 | 0.155 | 0.145 | Catechol O-methyltransferase inhibitor | 0.145 0.004 DB09526 0.036 0.018 DBMET02101 | DB09526 | |
| 0.057 | 0.202 | 0.215 | Nav1.4 sodium channel blocker | 0.147 0.035 DB09526 0.215 0.016 DBMET02101 | DBMET02101 | |
| 0.01 | 0.159 | 0.036 | Lysophosphatidic acid receptor 1 agonist | 0.036 0.007 DB01914 0.03 0.011 DB09526 | DB01914 | |
| 0.069 | 0.219 | 0.182 | Acetylcholine M1 receptor antagonist | 0.182 0.051 DB09526 | DB09526 | |
| 0.045 | 0.197 | 0.102 | Caspase 7 inhibitor | 0.102 0.026 DB09526 | DB09526 | |
| 0.07 | 0.223 | 0.327 | Aryl hydrocarbon receptor agonist | 0.327 0.054 DB09526 | DB09526 | |
| 0.083 | 0.237 | 0.352 | GABA C receptor rho-2 antagonist | 0.352 0.004 DB09526 0.122 0.121 DBMET02100 0.148 0.077 DBMET02101 | DB09526 | |
| 0.05 | 0.204 | 0.121 | Cyclooxygenase 2 inhibitor | 0.121 0.078 DB09526 0.116 0.084 DBMET02101 | DB09526 | |
| 0.036 | 0.191 | 0.106 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.106 0.01 DB09526 0.07 0.06 DBMET02101 | DB09526 | |
| 0.039 | 0.194 | 0.106 | Exportin-1 inhibitor | 0.078 0.029 DB01914 0.106 0.007 DB09526 | DB09526 | |
| 0.033 | 0.189 | 0.19 | Analgesic, opioid | 0.19 0.01 DB09526 0.081 0.047 DBMET02101 | DB09526 | |
| 0.02 | 0.177 | 0.084 | Beta 2 adrenoreceptor antagonist | 0.084 0.01 DB09526 | DB09526 | |
| 0.047 | 0.204 | 0.177 | GABA B receptor agonist | 0.082 0.039 DB01914 0.177 0.004 DB09526 0.094 0.021 DBMET02100 0.098 0.018 DBMET02101 | DB09526 | |
| 0.011 | 0.171 | 0.075 | Geranyltranstransferase inhibitor | 0.042 0.033 DB01914 0.075 0.006 DB09526 | DB09526 | |
| 0.051 | 0.211 | 0.126 | mTOR complex 2 inhibitor | 0.126 0.015 DB09526 | DB09526 | |
| 0.018 | 0.178 | 0.224 | Opioid mu receptor antagonist | 0.224 0.007 DB09526 | DB09526 | |
| 0.04 | 0.201 | 0.171 | Protease inhibitor | 0.171 0.022 DB01914 | DB01914 | |
| 0.01 | 0.173 | 0.143 | Estradiol 17 beta-dehydrogenase inhibitor | 0.143 0.006 DB09526 0.037 0.034 DBMET02101 | DB09526 | |
| 0.042 | 0.206 | 0.188 | Antineoplastic alkaloid | 0.188 0.017 DB09526 | DB09526 | |
| 0.008 | 0.172 | 0.087 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.087 0.005 DB09526 | DB09526 | |
| 0.003 | 0.167 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.013 DB09526 | DB09526 | |
| 0.029 | 0.196 | 0.09 | CD45 antagonist | 0.09 0.01 DB09526 | DB09526 | |
| 0.028 | 0.196 | 0.056 | Heme oxygenase inhibitor | 0.056 0.008 DB09526 | DB09526 | |
| 0.033 | 0.203 | 0.132 | Glutamate (mGluR7) antagonist | 0.132 0.004 DB09526 0.107 0.008 DBMET02100 | DB09526 | |
| 0.029 | 0.199 | 0.18 | MAO A inhibitor | 0.18 0.033 DB09526 | DB09526 | |
| 0.023 | 0.194 | 0.063 | Potassium channel (ATP-sensitive) activator | 0.063 0.014 DB09526 0.046 0.039 DBMET02101 | DB09526 | |
| 0.008 | 0.179 | 0.048 | Free fatty acid receptor 1 antagonist | 0.048 0.01 DB09526 0.045 0.012 DBMET02100 | DB09526 | |
| 0.025 | 0.197 | 0.066 | Potassium channel (Inward rectifier) activator | 0.066 0.014 DB09526 0.048 0.04 DBMET02101 | DB09526 | |
| 0.048 | 0.221 | 0.278 | GABA C receptor rho-1 antagonist | 0.12 0.04 DB01914 0.278 0.004 DB09526 0.089 0.08 DBMET02100 0.095 0.07 DBMET02101 | DB09526 | |
| 0.023 | 0.196 | 0.086 | Cyclin D1 inhibitor | 0.086 0.013 DB09526 | DB09526 | |
| 0.047 | 0.223 | 0.355 | GABA C receptor antagonist | 0.133 0.041 DB01914 0.355 0.004 DB09526 0.112 0.062 DBMET02100 0.24 0.007 DBMET02101 | DB09526 | |
| 0.003 | 0.179 | 0.024 | Carbonic anhydrase X inhibitor | 0.016 0.013 DB01914 0.024 0.006 DB09526 | DB09526 | |
| 0.003 | 0.179 | 0.024 | Carbonic anhydrase VIII inhibitor | 0.016 0.013 DB01914 0.024 0.006 DB09526 | DB09526 | |
| 0.007 | 0.182 | 0.041 | Lysine carboxypeptidase inhibitor | 0.025 0.021 DB01914 0.041 0.01 DB09526 | DB09526 | |
| 0.011 | 0.188 | 0.041 | Calcitonin receptor agonist | 0.034 0.023 DB01914 0.041 0.02 DB09526 | DB09526 | |
| 0.005 | 0.185 | 0.027 | Leukotriene B4 receptor 1 antagonist | 0.027 0.02 DB09526 | DB09526 | |
| 0.01 | 0.191 | 0.026 | ICAM 1 antagonist | 0.026 0.01 DB09526 | DB09526 | |
| 0.035 | 0.217 | 0.25 | Opioid antagonist | 0.25 0.008 DB09526 | DB09526 | |
| 0.065 | 0.247 | 0.645 | Dual specificity phosphatase 3 inhibitor | 0.329 0.024 DB09526 0.645 0.004 DBMET02101 | DBMET02101 | |
| 0.009 | 0.193 | 0.094 | Dihydropteroate synthase inhibitor | 0.094 0.005 DB09526 0.046 0.02 DBMET02101 | DB09526 | |
| 0.029 | 0.214 | 0.09 | Pregnane X receptor antagonist | 0.053 0.05 DB01914 0.09 0.004 DB09526 0.058 0.037 DBMET02100 | DB09526 | |
| 0.033 | 0.218 | 0.123 | Beta 3 adrenoreceptor antagonist | 0.123 0.009 DB09526 0.065 0.043 DBMET02101 | DB09526 | |
| 0.008 | 0.195 | 0.02 | Caspase 8 inhibitor | 0.02 0.014 DB09526 | DB09526 | |
| 0.005 | 0.194 | 0.029 | Thyroid hormone alpha antagonist | 0.029 0.005 DB09526 | DB09526 | |
| 0.102 | 0.292 | 0.743 | Superoxide dismutase inhibitor | 0.412 0.025 DB01914 0.653 0.005 DB09526 0.311 0.047 DBMET02100 0.743 0.004 DBMET02101 | DBMET02101 | |
| 0.039 | 0.229 | 0.173 | Bronchodilator | 0.173 0.024 DB09526 0.105 0.059 DBMET02100 | DB09526 | |
| 0.004 | 0.195 | 0.048 | Nicotinic acid receptor 1 antagonist | 0.048 0.003 DB09526 0.022 0.007 DBMET02100 | DB09526 | |
| 0.001 | 0.193 | 0.012 | Progesterone receptor A antagonist | 0.012 0.005 DB09526 | DB09526 | |
| 0.027 | 0.22 | 0.112 | Dihydroorotate oxidase inhibitor | 0.112 0.004 DB09526 0.062 0.025 DBMET02100 0.063 0.024 DBMET02101 | DB09526 | |
| 0.039 | 0.233 | 0.096 | Transcription factor RelA inhibitor | 0.096 0.008 DB09526 | DB09526 | |
| 0.055 | 0.25 | 0.186 | Cathepsin H inhibitor | 0.158 0.041 DB01914 0.186 0.027 DB09526 0.118 0.077 DBMET02100 0.108 0.093 DBMET02101 | DB09526 | |
| 0.011 | 0.21 | 0.111 | Aromatase inhibitor | 0.111 0.019 DB09526 0.081 0.027 DBMET02101 | DB09526 | |
| 0.026 | 0.224 | 0.108 | Beta adrenoreceptor antagonist | 0.108 0.014 DB09526 | DB09526 | |
| 0.014 | 0.213 | 0.233 | Opioid delta receptor antagonist | 0.233 0.007 DB09526 | DB09526 | |
| 0.037 | 0.238 | 0.084 | Heme oxygenase stimulant | 0.084 0.013 DB09526 0.06 0.045 DBMET02100 | DB09526 | |
| 0.029 | 0.231 | 0.064 | DNA helicase inhibitor | 0.064 0.022 DB09526 | DB09526 | |
| 0.017 | 0.221 | 0.106 | Adenylate cyclase 1 inhibitor | 0.106 0.004 DB09526 | DB09526 | |
| 0.078 | 0.282 | 0.213 | Tumour necrosis factor antagonist | 0.213 0.046 DB09526 0.137 0.118 DBMET02100 | DB09526 | |
| 0.01 | 0.219 | 0.083 | Estrogen-related receptor alpha antagonist | 0.083 0.008 DB09526 | DB09526 | |
| 0.013 | 0.224 | 0.05 | Membrane dipeptidase inhibitor | 0.038 0.03 DB01914 0.05 0.016 DB09526 | DB09526 | |
| 0.011 | 0.223 | 0.082 | Opioid kappa receptor agonist | 0.082 0.012 DB09526 | DB09526 | |
| 0.04 | 0.257 | 0.1 | Phosphodiesterase I inhibitor | 0.1 0.044 DB09526 | DB09526 | |
| 0.019 | 0.237 | 0.058 | Vanilloid 3 antagonist | 0.058 0.005 DB09526 | DB09526 | |
| 0.003 | 0.222 | 0.021 | Cyclin T1 inhibitor | 0.021 0.01 DB09526 | DB09526 | |
| 0.039 | 0.258 | 0.108 | Alpha 2c adrenoreceptor antagonist | 0.108 0.059 DB09526 | DB09526 | |
| 0.012 | 0.232 | 0.211 | Alpha tubulin antagonist | 0.211 0.005 DB09526 | DB09526 | |
| 0.004 | 0.224 | 0.041 | Dopamine autoreceptor agonist | 0.041 0.009 DB09526 | DB09526 | |
| 0.011 | 0.233 | 0.128 | Opioid agonist | 0.128 0.009 DB09526 | DB09526 | |
| 0.084 | 0.311 | 0.212 | Lipocortins synthesis antagonist | 0.179 0.072 DB09526 0.212 0.049 DBMET02100 | DBMET02100 | |
| 0.008 | 0.239 | 0.118 | Plasmepsin I inhibitor | 0.118 0.003 DB01914 | DB01914 | |
| 0.001 | 0.233 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DB09526 | DB09526 | |
| 0.039 | 0.271 | 0.13 | Acetylcholine muscarinic antagonist | 0.13 0.058 DB09526 | DB09526 | |
| 0.007 | 0.239 | 0.042 | Liver X receptor beta agonist | 0.042 0.014 DB09526 | DB09526 | |
| 0.028 | 0.262 | 0.161 | Histamine N-methyltransferase inhibitor | 0.161 0.011 DB09526 | DB09526 | |
| 0.027 | 0.261 | 0.159 | Adrenaline agonist | 0.159 0.013 DB09526 | DB09526 | |
| 0.003 | 0.24 | 0.023 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.023 0.004 DB09526 | DB09526 | |
| 0.002 | 0.24 | 0.01 | Imidazoline I2 receptor antagonist | 0.01 0.009 DB09526 | DB09526 | |
| 0.007 | 0.248 | 0.055 | Liver X receptor beta antagonist | 0.055 0.007 DB09526 | DB09526 | |
| 0.008 | 0.25 | 0.058 | Retinoid X alpha receptor agonist | 0.058 0.012 DB09526 | DB09526 | |
| 0.019 | 0.265 | 0.117 | Dopamine beta hydroxylase inhibitor | 0.045 0.043 DB01914 0.117 0.003 DB09526 | DB09526 | |
| 0.018 | 0.264 | 0.048 | HCV NS3/NS4A protease inhibitor | 0.048 0.037 DB09526 | DB09526 | |
| 0.009 | 0.258 | 0.054 | Thromboxane A2 antagonist | 0.054 0.032 DB09526 | DB09526 | |
| 0.021 | 0.273 | 0.074 | 5 Hydroxytryptamine 7 agonist | 0.074 0.017 DB09526 | DB09526 | |
| 0.021 | 0.275 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | 0.064 0.024 DB09526 | DB09526 | |
| 0.014 | 0.269 | 0.038 | Plasmepsin II inhibitor | 0.038 0.034 DB09526 | DB09526 | |
| 0.006 | 0.262 | 0.024 | Lysophosphatidic acid 1 receptor antagonist | 0.024 0.011 DBMET02100 | DBMET02100 | |
| 0.014 | 0.27 | 0.132 | Dopamine agonist | 0.132 0.018 DB09526 0.122 0.02 DBMET02101 | DB09526 | |
| 0.009 | 0.266 | 0.072 | GABA uptake inhibitor | 0.057 0.011 DB01914 0.072 0.006 DB09526 0.045 0.02 DBMET02100 | DB09526 | |
| 0.005 | 0.263 | 0.049 | Farnesoid X receptor agonist | 0.043 0.02 DB09526 0.049 0.015 DBMET02100 0.04 0.023 DBMET02101 | DBMET02100 | |
| 0.005 | 0.264 | 0.06 | Retinoid X receptor agonist | 0.06 0.014 DB09526 | DB09526 | |
| 0.011 | 0.271 | 0.058 | Thromboxane antagonist | 0.058 0.034 DB09526 | DB09526 | |
| 0.017 | 0.28 | 0.084 | Sphingosine 1-phosphate receptor 3 antagonist | 0.084 0.014 DB09526 0.058 0.042 DBMET02100 | DB09526 | |
| 0.093 | 0.356 | 0.271 | DNA directed DNA polymerase inhibitor | 0.271 0.178 DB09526 | DB09526 | |
| 0.015 | 0.279 | 0.091 | Beta 1 adrenoreceptor antagonist | 0.054 0.041 DB01914 0.091 0.013 DB09526 | DB09526 | |
| 0.009 | 0.274 | 0.029 | Integrin alpha2beta1 antagonist | 0.029 0.014 DB09526 | DB09526 | |
| 0.003 | 0.27 | 0.03 | Prostaglandin H2 antagonist | 0.03 0.014 DB09526 | DB09526 | |
| 0.023 | 0.29 | 0.193 | MAO inhibitor | 0.193 0.043 DB09526 | DB09526 | |
| 0.019 | 0.289 | 0.16 | Androgen antagonist | 0.16 0.02 DB09526 | DB09526 | |
| 0.066 | 0.337 | 0.264 | Growth hormone agonist | 0.264 0.04 DB09526 | DB09526 | |
| 0.021 | 0.294 | 0.072 | Prostaglandin F2 alpha antagonist | 0.06 0.046 DB09526 0.072 0.03 DBMET02100 | DBMET02100 | |
| 0.007 | 0.28 | 0.051 | Matrix metalloproteinase 1 inhibitor | 0.051 0.038 DB09526 | DB09526 | |
| 0.038 | 0.311 | 0.12 | Cholinergic antagonist | 0.12 0.074 DB09526 | DB09526 | |
| 0.031 | 0.305 | 0.363 | Ferrochelatase inhibitor | 0.152 0.037 DB01914 0.363 0.004 DB09526 0.104 0.067 DBMET02100 0.093 0.079 DBMET02101 | DB09526 | |
| 0.057 | 0.33 | 0.161 | Antimitotic | 0.161 0.112 DB09526 | DB09526 | |
| 0.006 | 0.28 | 0.045 | Nicotinic acid receptor 2 antagonist | 0.045 0.004 DB09526 | DB09526 | |
| 0.006 | 0.282 | 0.025 | Retinoid X beta receptor antagonist | 0.025 0.007 DB09526 | DB09526 | |
| 0.029 | 0.309 | 0.163 | Gastric antisecretory | 0.118 0.044 DB09526 0.163 0.021 DBMET02101 | DBMET02101 | |
| 0.011 | 0.292 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.019 DB09526 | DB09526 | |
| 0.036 | 0.32 | 0.116 | Acetylcholine antagonist | 0.116 0.074 DB09526 | DB09526 | |
| 0.075 | 0.36 | 0.213 | Papain-like protease (SARS coronavirus) inhibitor | 0.213 0.008 DB09526 0.116 0.093 DBMET02100 | DB09526 | |
| 0.001 | 0.287 | 0.01 | DNA topoisomerase III inhibitor | 0.01 0.004 DB09526 | DB09526 | |
| 0.021 | 0.308 | 0.303 | Cathepsin G inhibitor | 0.119 0.027 DB09526 0.303 0.009 DBMET02101 | DBMET02101 | |
| 0.038 | 0.327 | 0.083 | Calcium channel P-type blocker | 0.083 0.012 DB09526 | DB09526 | |
| 0.042 | 0.331 | 0.106 | Electron transport complex I inhibitor | 0.106 0.069 DB09526 | DB09526 | |
| 0.054 | 0.344 | 0.17 | Sphingosine 1-phosphate receptor 4 antagonist | 0.115 0.083 DB01914 0.17 0.019 DB09526 0.136 0.048 DBMET02100 | DB09526 | |
| 0.008 | 0.3 | 0.077 | Potassium channel Kv1.3 blocker | 0.077 0.013 DB09526 | DB09526 | |
| 0.072 | 0.365 | 0.352 | Lipoxygenase inhibitor | 0.352 0.05 DB09526 | DB09526 | |
| 0.012 | 0.309 | 0.049 | Erythropoietin receptor agonist | 0.049 0.022 DB09526 | DB09526 | |
| 0.045 | 0.345 | 0.143 | Nav1.2 sodium channel blocker | 0.143 0.062 DB09526 0.125 0.077 DBMET02101 | DB09526 | |
| 0.006 | 0.305 | 0.016 | Integrin beta6 antagonist | 0.016 0.007 DB09526 | DB09526 | |
| 0.043 | 0.344 | 0.119 | Cytokine production inhibitor | 0.119 0.09 DB09526 | DB09526 | |
| 0.044 | 0.346 | 0.639 | Dual specificity phosphatase inhibitor | 0.332 0.024 DB09526 0.639 0.004 DBMET02101 | DBMET02101 | |
| 0.025 | 0.328 | 0.159 | Myeloperoxidase inhibitor | 0.159 0.009 DB09526 | DB09526 | |
| 0.005 | 0.31 | 0.024 | Alpha 2b adrenoreceptor agonist | 0.024 0.006 DB09526 | DB09526 | |
| 0.003 | 0.31 | 0.021 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.021 0.013 DB09526 | DB09526 | |
| 0.032 | 0.34 | 0.361 | Multidrug resistance-associated protein 1 inhibitor | 0.103 0.073 DB09526 0.361 0.003 DBMET02101 | DBMET02101 | |
| 0.008 | 0.325 | 0.149 | NMDA receptor subunit 3B antagonist | 0.149 0.006 DB09526 0.058 0.02 DBMET02100 | DB09526 | |
| 0.014 | 0.332 | 0.085 | Acetylcholine nicotinic antagonist | 0.085 0.05 DB09526 | DB09526 | |
| 0.021 | 0.34 | 0.058 | Bombesin 2 receptor antagonist | 0.058 0.025 DB09526 | DB09526 | |
| 0.009 | 0.328 | 0.052 | Delayed rectifier potassium channel blocker | 0.052 0.01 DB09526 | DB09526 | |
| 0.011 | 0.332 | 0.04 | Integrin alpha2 antagonist | 0.04 0.02 DB09526 | DB09526 | |
| 0.017 | 0.339 | 0.083 | Metalloproteinase-2 inhibitor | 0.083 0.05 DB09526 | DB09526 | |
| 0.004 | 0.327 | 0.037 | Glutamate (mGluR group II) antagonist | 0.037 0.029 DB09526 0.035 0.032 DBMET02100 | DB09526 | |
| 0.026 | 0.349 | 0.075 | Peroxisome proliferator-activated receptor gamma antagonist | 0.075 0.042 DB09526 | DB09526 | |
| 0.004 | 0.328 | 0.148 | Glutamate (mGluR1a) agonist | 0.08 0.004 DB09526 0.148 0.003 DBMET02101 | DBMET02101 | |
| 0.012 | 0.336 | 0.063 | Matrix metalloproteinase inhibitor | 0.063 0.051 DB09526 | DB09526 | |
| 0.006 | 0.332 | 0.036 | Cholesterol ester transfer protein antagonist | 0.036 0.017 DB09526 0.035 0.017 DBMET02101 | DB09526 | |
| 0.004 | 0.332 | 0.046 | Nicotinic alpha3beta4 receptor agonist | 0.046 0.007 DB09526 | DB09526 | |
| 0.004 | 0.34 | 0.023 | Imidazoline I1 receptor antagonist | 0.023 0.011 DB09526 | DB09526 | |
| 0.035 | 0.372 | 0.066 | Prolactin release inhibitor | 0.066 0.031 DB09526 | DB09526 | |
| 0.001 | 0.339 | 0.012 | Carbonic anhydrase XI inhibitor | 0.012 0.009 DB09526 | DB09526 | |
| 0.005 | 0.345 | 0.116 | NMDA receptor subunit 3A antagonist | 0.116 0.007 DB09526 0.047 0.021 DBMET02100 | DB09526 | |
| 0.007 | 0.348 | 0.089 | Nicotinic acid receptor agonist | 0.089 0.005 DB09526 0.035 0.026 DBMET02100 | DB09526 | |
| 0.007 | 0.349 | 0.077 | Acetylcholine M3 receptor antagonist | 0.077 0.027 DB09526 | DB09526 | |
| 0.007 | 0.35 | 0.149 | MAO B inhibitor | 0.149 0.038 DB09526 | DB09526 | |
| 0.052 | 0.395 | 0.183 | Antipruritic | 0.183 0.061 DB09526 | DB09526 | |
| 0.058 | 0.402 | 0.146 | MAP kinase 3 inhibitor | 0.146 0.073 DB09526 | DB09526 | |
| 0.018 | 0.362 | 0.036 | Glucose-6-phosphate dehydrogenase inhibitor | 0.036 0.03 DB09526 | DB09526 | |
| 0.003 | 0.348 | 0.036 | Progesterone antagonist | 0.036 0.024 DB09526 | DB09526 | |
| 0.003 | 0.348 | 0.045 | Alpha 2a adrenoreceptor agonist | 0.045 0.004 DB09526 | DB09526 | |
| 0.032 | 0.378 | 0.197 | Electrolyte absorption antagonist | 0.113 0.043 DB01914 0.197 0.008 DB09526 0.099 0.058 DBMET02100 | DB09526 | |
| 0.031 | 0.377 | 0.144 | Proteasome inhibitor | 0.096 0.093 DB01914 0.144 0.05 DB09526 | DB09526 | |
| 0.072 | 0.418 | 0.221 | MAP kinase kinase 4 inhibitor | 0.221 0.008 DB09526 | DB09526 | |
| 0.012 | 0.361 | 0.063 | GABA B receptor antagonist | 0.063 0.011 DB09526 | DB09526 | |
| 0.004 | 0.354 | 0.064 | Urate transporter 1 inhibitor | 0.064 0.013 DB09526 | DB09526 | |
| 0.012 | 0.365 | 0.051 | Retinoid X receptor antagonist | 0.051 0.012 DB09526 | DB09526 | |
| 0.017 | 0.37 | 0.08 | Botulinum neurotoxin type A inhibitor | 0.08 0.017 DB09526 | DB09526 | |
| 0.023 | 0.376 | 0.088 | Sphingosine 1-phosphate receptor antagonist | 0.088 0.032 DB09526 | DB09526 | |
| 0.01 | 0.363 | 0.075 | Neuronal nicotinic receptor antagonist | 0.075 0.041 DB09526 | DB09526 | |
| 0.012 | 0.368 | 0.135 | Sphingosine 1-phosphate receptor 4 agonist | 0.071 0.044 DB01914 0.135 0.012 DB09526 | DB09526 | |
| 0.028 | 0.384 | 0.249 | Opioid kappa receptor antagonist | 0.249 0.007 DB09526 | DB09526 | |
| 0.002 | 0.358 | 0.018 | Egl nine homolog 3 inhibitor | 0.018 0.005 DB09526 | DB09526 | |
| 0.015 | 0.375 | 0.066 | Lysine-specific demethylase 1A inhibitor | 0.066 0.021 DB09526 | DB09526 | |
| 0.008 | 0.369 | 0.067 | Neutrophil collagenase inhibitor | 0.067 0.043 DB09526 | DB09526 | |
| 0.006 | 0.37 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.04 0.016 DB09526 | DB09526 | |
| 0.013 | 0.38 | 0.16 | Anesthetic local | 0.097 0.085 DB01914 0.16 0.044 DB09526 | DB09526 | |
| 0.008 | 0.377 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.025 DB09526 0.032 0.025 DBMET02101 | DBMET02101 | |
| 0.003 | 0.372 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.03 0.008 DB09526 | DB09526 | |
| 0.02 | 0.389 | 0.182 | Falcipain 3 inhibitor | 0.119 0.054 DB01914 0.182 0.024 DB09526 | DB09526 | |
| 0.014 | 0.384 | 0.111 | Inducible nitric-oxide synthase inhibitor | 0.106 0.032 DB09526 0.111 0.029 DBMET02101 | DBMET02101 | |
| 0.006 | 0.376 | 0.099 | Alpha 1d adrenoreceptor agonist | 0.099 0.004 DB09526 | DB09526 | |
| 0.01 | 0.38 | 0.033 | Complement factor 1s inhibitor | 0.033 0.005 DB09526 | DB09526 | |
| 0.011 | 0.382 | 0.042 | Retinoid X alpha receptor antagonist | 0.042 0.012 DB09526 | DB09526 | |
| 0.077 | 0.449 | 0.252 | Catenin beta inhibitor | 0.252 0.01 DB09526 0.157 0.09 DBMET02100 | DB09526 | |
| 0.108 | 0.484 | 0.267 | 5 Hydroxytryptamine 3E antagonist | 0.171 0.131 DB01914 0.267 0.01 DB09526 0.176 0.116 DBMET02101 | DB09526 | |
| 0.024 | 0.402 | 0.103 | Acetylcholinesterase inhibitor | 0.103 0.1 DB09526 | DB09526 | |
| 0.142 | 0.524 | 0.501 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.324 0.182 DB01914 0.501 0.033 DB09526 0.293 0.222 DBMET02100 | DB09526 | |
| 0.054 | 0.437 | 0.412 | 12-Lipoxygenase inhibitor | 0.412 0.036 DB09526 | DB09526 | |
| 0.033 | 0.42 | 0.082 | MDM2 inhibitor | 0.082 0.017 DB09526 | DB09526 | |
| 0.01 | 0.398 | 0.036 | Melatonin receptor 1A agonist | 0.036 0.018 DB09526 | DB09526 | |
| 0.018 | 0.406 | 0.162 | Urease inhibitor | 0.162 0.018 DB09526 | DB09526 | |
| 0.014 | 0.405 | 0.072 | Glutamate (mGluR8) antagonist | 0.072 0.004 DBMET02100 | DBMET02100 | |
| 0.002 | 0.393 | 0.031 | NMDA receptor glycine site antagonist | 0.031 0.012 DB09526 | DB09526 | |
| 0.009 | 0.4 | 0.053 | Dopamine uptake inhibitor | 0.053 0.045 DB09526 | DB09526 | |
| 0.007 | 0.399 | 0.072 | Glycine transporter 2 inhibitor | 0.072 0.02 DB09526 | DB09526 | |
| 0.023 | 0.417 | 0.128 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.128 0.021 DB09526 | DB09526 | |
| 0.027 | 0.421 | 0.078 | Immunoglobulin Fc receptor antagonist | 0.078 0.007 DB09526 | DB09526 | |
| 0.009 | 0.403 | 0.049 | Matrix metalloproteinase (membrane-type) inhibitor | 0.049 0.047 DB09526 | DB09526 | |
| 0.004 | 0.401 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 DB09526 | DB09526 | |
| 0.006 | 0.41 | 0.057 | Acetylcholine M2 receptor antagonist | 0.057 0.048 DB09526 | DB09526 | |
| 0.004 | 0.408 | 0.047 | Diamine oxidase inhibitor | 0.047 0.016 DB09526 | DB09526 | |
| 0.018 | 0.424 | 0.222 | Tubulin antagonist | 0.222 0.031 DB09526 | DB09526 | |
| 0.036 | 0.443 | 0.125 | Glutamate (mGluR7) agonist | 0.125 0.026 DB09526 | DB09526 | |
| 0.006 | 0.413 | 0.041 | Liver X receptor alpha antagonist | 0.041 0.009 DB09526 | DB09526 | |
| 0.018 | 0.426 | 0.07 | Nicotinic alpha3beta2 receptor antagonist | 0.07 0.018 DB09526 | DB09526 | |
| 0.01 | 0.418 | 0.061 | Protein kinase (CK2) beta inhibitor | 0.061 0.005 DB09526 | DB09526 | |
| 0.006 | 0.415 | 0.047 | Lysophosphatidic acid 2 receptor antagonist | 0.047 0.009 DB09526 | DB09526 | |
| 0.02 | 0.432 | 0.077 | Vanilloid 2 antagonist | 0.077 0.01 DB09526 | DB09526 | |
| 0.013 | 0.429 | 0.142 | NMDA receptor agonist | 0.117 0.014 DB09526 0.142 0.009 DBMET02101 | DBMET02101 | |
| 0.016 | 0.432 | 0.106 | 5 Hydroxytryptamine 3 agonist | 0.106 0.013 DB09526 | DB09526 | |
| 0.009 | 0.426 | 0.096 | 5 Hydroxytryptamine 2A agonist | 0.096 0.016 DB09526 | DB09526 | |
| 0.014 | 0.435 | 0.088 | Potassium channel (ATP-sensitive) blocker | 0.088 0.022 DB09526 | DB09526 | |
| 0.003 | 0.427 | 0.038 | Nicotinic alpha4beta2 receptor agonist | 0.038 0.009 DB09526 | DB09526 | |
| 0.012 | 0.436 | 0.109 | Dopamine D1 antagonist | 0.109 0.022 DB09526 | DB09526 | |
| 0.007 | 0.432 | 0.073 | Glutamate (mGluR1) agonist | 0.039 0.005 DB09526 0.073 0.004 DBMET02101 | DBMET02101 | |
| 0.007 | 0.431 | 0.109 | NMDA receptor glycine site agonist | 0.109 0.013 DB09526 | DB09526 | |
| 0.002 | 0.426 | 0.018 | Egl nine homolog 1 inhibitor | 0.018 0.006 DB09526 | DB09526 | |
| 0.005 | 0.432 | 0.026 | LFA antagonist | 0.026 0.022 DB09526 | DB09526 | |
| 0.009 | 0.437 | 0.042 | Tryptophan 5 hydroxylase inhibitor | 0.042 0.012 DB09526 | DB09526 | |
| 0.015 | 0.443 | 0.136 | Heat shock protein 90 beta antagonist | 0.136 0.005 DB09526 | DB09526 | |
| 0.021 | 0.449 | 0.143 | MAP kinase kinase 1 inhibitor | 0.116 0.039 DB01914 0.143 0.019 DB09526 | DB09526 | |
| 0.015 | 0.445 | 0.105 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.105 0.009 DB09526 | DB09526 | |
| 0.012 | 0.443 | 0.149 | CYP2A6 inhibitor | 0.149 0.016 DB09526 | DB09526 | |
| 0.007 | 0.44 | 0.092 | Acetylcholine M5 receptor agonist | 0.092 0.025 DB09526 | DB09526 | |
| 0.004 | 0.438 | 0.034 | TRPM8 blocker | 0.034 0.032 DB09526 | DB09526 | |
| 0.005 | 0.44 | 0.123 | NMDA 2C receptor antagonist | 0.12 0.01 DB09526 0.123 0.01 DBMET02101 | DBMET02101 | |
| 0.007 | 0.443 | 0.063 | Dihydroorotate dehydrogenase inhibitor | 0.063 0.026 DB09526 | DB09526 | |
| 0.037 | 0.475 | 0.187 | Sphingosine 1-phosphate receptor 2 antagonist | 0.187 0.011 DB09526 | DB09526 | |
| 0.01 | 0.448 | 0.075 | HIV-1 reverse transcriptase inhibitor | 0.075 0.045 DBMET02101 | DBMET02101 | |
| 0.022 | 0.464 | 0.18 | Nav1.6 sodium channel blocker | 0.18 0.028 DB09526 | DB09526 | |
| 0.006 | 0.449 | 0.021 | CYP24 inhibitor | 0.021 0.018 DB09526 | DB09526 | |
| 0.004 | 0.449 | 0.051 | Sphingosine 1-phosphate receptor 1 agonist | 0.051 0.019 DB01914 0.043 0.027 DB09526 | DB01914 | |
| 0.041 | 0.488 | 0.141 | CC chemokine 5 receptor agonist | 0.141 0.004 DB09526 0.138 0.005 DBMET02101 | DB09526 | |
| 0.009 | 0.46 | 0.061 | Thromboxane synthase inhibitor | 0.061 0.026 DB09526 | DB09526 | |
| 0.014 | 0.466 | 0.081 | Alpha 2 adrenoreceptor antagonist | 0.081 0.065 DB09526 | DB09526 | |
| 0.05 | 0.503 | 0.23 | Histone acetyltransferase inhibitor | 0.23 0.036 DB09526 | DB09526 | |
| 0.017 | 0.472 | 0.07 | Histone deacetylase SIRT3 inhibitor | 0.07 0.028 DB09526 | DB09526 | |
| 0.01 | 0.465 | 0.094 | H+/K+-transporting ATPase inhibitor | 0.094 0.009 DBMET02101 | DBMET02101 | |
| 0.003 | 0.459 | 0.228 | Estrone sulfatase inhibitor | 0.027 0.012 DB09526 0.228 0.002 DBMET02101 | DBMET02101 | |
| 0.002 | 0.462 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.012 DB09526 | DB09526 | |
| 0.013 | 0.474 | 0.077 | Alpha 2a adrenoreceptor antagonist | 0.077 0.051 DB09526 | DB09526 | |
| 0.013 | 0.475 | 0.094 | Calcium antagonist | 0.094 0.052 DB09526 | DB09526 | |
| 0.003 | 0.467 | 0.067 | Fructose-1,6-bisphosphatase inhibitor | 0.067 0.014 DB09526 | DB09526 | |
| 0.012 | 0.478 | 0.083 | Secretase beta inhibitor | 0.083 0.032 DB09526 | DB09526 | |
| 0.004 | 0.473 | 0.052 | Calpain 1 inhibitor | 0.052 0.005 DB01914 | DB01914 | |
| 0.005 | 0.479 | 0.105 | NMDA 2A receptor antagonist | 0.105 0.012 DB09526 0.075 0.022 DBMET02101 | DB09526 | |
| 0.013 | 0.489 | 0.047 | CC chemokine 4 receptor antagonist | 0.047 0.032 DB09526 | DB09526 | |
| 0.004 | 0.482 | 0.035 | Protocollagen prolyl hydroxylase inhibitor | 0.035 0.01 DB09526 | DB09526 | |
| 0.007 | 0.487 | 0.06 | Dihydroorotase inhibitor | 0.06 0.016 DB09526 | DB09526 | |
| 0.004 | 0.485 | 0.051 | 5 Hydroxytryptamine 2 agonist | 0.051 0.037 DB09526 | DB09526 | |
| 0.013 | 0.495 | 0.067 | Glutamate (mGluR group III) antagonist | 0.067 0.01 DB09526 0.044 0.03 DBMET02100 | DB09526 | |
| 0.01 | 0.493 | 0.356 | 5-Lipoxygenase inhibitor | 0.356 0.007 DB09526 | DB09526 | |
| 0.027 | 0.511 | 0.151 | Cyclin-dependent kinase 8 inhibitor | 0.151 0.079 DB09526 | DB09526 | |
| 0.004 | 0.489 | 0.027 | Acid ceramidase inhibitor | 0.027 0.014 DB09526 | DB09526 | |
| 0.034 | 0.518 | 0.175 | Pregnane X receptor agonist | 0.175 0.022 DB09526 0.143 0.067 DBMET02101 | DB09526 | |
| 0.011 | 0.496 | 0.047 | Potassium channel Kv1.1 blocker | 0.047 0.015 DB09526 | DB09526 | |
| 0.003 | 0.489 | 0.046 | Sirtuin 2 inhibitor | 0.046 0.014 DB09526 | DB09526 | |
| 0.002 | 0.488 | 0.019 | Alpha 2c adrenoreceptor agonist | 0.019 0.013 DB09526 | DB09526 | |
| 0.028 | 0.516 | 0.242 | Calpain inhibitor | 0.242 0.073 DB09526 | DB09526 | |
| 0.003 | 0.494 | 0.047 | CXC chemokine 2 receptor antagonist | 0.047 0.006 DB09526 | DB09526 | |
| 0.005 | 0.498 | 0.042 | Liver X receptor antagonist | 0.042 0.013 DB09526 | DB09526 | |
| 0.025 | 0.518 | 0.262 | Heat shock protein 90 alpha antagonist | 0.262 0.023 DB09526 | DB09526 | |
| 0.003 | 0.496 | 0.029 | Methionyl aminopeptidase 2 inhibitor | 0.029 0.014 DB09526 | DB09526 | |
| 0.004 | 0.502 | 0.181 | Beta tubulin antagonist | 0.181 0.009 DB09526 | DB09526 | |
| 0.007 | 0.505 | 0.043 | Glutamate (mGluR4) agonist | 0.043 0.014 DB09526 | DB09526 | |
| 0.006 | 0.505 | 0.047 | 5 Hydroxytryptamine 4 antagonist | 0.047 0.044 DB09526 | DB09526 | |
| 0.011 | 0.513 | 0.085 | Bcr-Abl kinase inhibitor | 0.085 0.058 DB09526 | DB09526 | |
| 0.001 | 0.505 | 0.019 | Kainate receptor 1 antagonist | 0.019 0.016 DB09526 | DB09526 | |
| 0.005 | 0.512 | 0.216 | NMDA receptor antagonist | 0.168 0.02 DB09526 0.216 0.012 DBMET02101 | DBMET02101 | |
| 0.039 | 0.548 | 0.449 | 15-Lipoxygenase inhibitor | 0.449 0.055 DB09526 0.396 0.076 DBMET02101 | DB09526 | |
| 0.045 | 0.554 | 0.199 | Sphingosine 1-phosphate receptor 5 antagonist | 0.199 0.012 DB09526 0.149 0.063 DBMET02100 | DB09526 | |
| 0.032 | 0.541 | 0.134 | Histone deacetylase SIRT1 inhibitor | 0.134 0.076 DB09526 | DB09526 | |
| 0.01 | 0.52 | 0.083 | Carbonic anhydrase stimulant | 0.083 0.024 DB09526 | DB09526 | |
| 0.057 | 0.566 | 0.363 | Insulysin inhibitor | 0.363 0.03 DB09526 0.189 0.175 DBMET02100 0.225 0.123 DBMET02101 | DB09526 | |
| 0.01 | 0.52 | 0.353 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.353 0.035 DB09526 | DB09526 | |
| 0.006 | 0.517 | 0.066 | Cyclin-dependent kinase 6 inhibitor | 0.066 0.035 DB09526 | DB09526 | |
| 0.017 | 0.528 | 0.251 | 5 Hydroxytryptamine 3A agonist | 0.251 0.005 DB09526 | DB09526 | |
| 0.026 | 0.541 | 0.262 | Amyloid beta precursor protein antagonist | 0.262 0.028 DB09526 | DB09526 | |
| 0.013 | 0.532 | 0.105 | Potassium channel activator | 0.105 0.043 DB09526 | DB09526 | |
| 0.004 | 0.524 | 0.045 | Sphingosine 1-phosphate receptor agonist | 0.045 0.03 DB01914 0.044 0.032 DB09526 | DB01914 | |
| 0.012 | 0.532 | 0.068 | Glutamate (mGluR4) antagonist | 0.068 0.011 DB09526 | DB09526 | |
| 0.014 | 0.538 | 0.404 | M18 aspartyl aminopeptidase inhibitor | 0.404 0.005 DB09526 | DB09526 | |
| 0.007 | 0.531 | 0.075 | Plasminogen activator inhibitor antagonist | 0.075 0.017 DB09526 0.075 0.017 DBMET02100 | DBMET02100 | |
| 0.007 | 0.532 | 0.068 | Acetylcholine M5 receptor antagonist | 0.068 0.033 DB09526 | DB09526 | |
| 0.004 | 0.53 | 0.037 | Histone deacetylase 8 inhibitor | 0.037 0.033 DB09526 | DB09526 | |
| 0.007 | 0.533 | 0.045 | 5 Hydroxytryptamine 2B agonist | 0.045 0.018 DB09526 | DB09526 | |
| 0.004 | 0.531 | 0.055 | Nicotinic receptor alpha7 subunit antagonist | 0.055 0.034 DB09526 | DB09526 | |
| 0.012 | 0.539 | 0.108 | Nitric-oxide synthase inhibitor | 0.108 0.048 DB09526 0.087 0.084 DBMET02101 | DB09526 | |
| 0.011 | 0.538 | 0.053 | Neurotensin receptor antagonist | 0.053 0.026 DB09526 | DB09526 | |
| 0.004 | 0.532 | 0.033 | Angiotensin II receptor antagonist | 0.033 0.026 DB09526 | DB09526 | |
| 0.004 | 0.535 | 0.214 | Leukocyte elastase inhibitor | 0.039 0.035 DB09526 0.214 0.004 DBMET02101 | DBMET02101 | |
| 0.004 | 0.535 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.016 0.009 DB09526 | DB09526 | |
| 0.003 | 0.536 | 0.029 | Glucagon receptor antagonist | 0.029 0.021 DB09526 | DB09526 | |
| 0.005 | 0.539 | 0.061 | Nerve growth factor antagonist | 0.061 0.009 DB09526 | DB09526 | |
| 0.005 | 0.539 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.033 DB09526 | DB09526 | |
| 0.004 | 0.54 | 0.03 | Peptide deformylase inhibitor | 0.03 0.022 DB09526 | DB09526 | |
| 0.006 | 0.542 | 0.045 | Benzodiazepine antagonist | 0.045 0.04 DB09526 | DB09526 | |
| 0.006 | 0.544 | 0.054 | Collagenase 3 inhibitor | 0.054 0.05 DB09526 | DB09526 | |
| 0.006 | 0.546 | 0.059 | AMPA 4 receptor antagonist | 0.059 0.01 DB09526 | DB09526 | |
| 0.005 | 0.546 | 0.053 | Nicotinic acid receptor 2 agonist | 0.053 0.013 DB09526 0.035 0.026 DBMET02100 | DB09526 | |
| 0.033 | 0.577 | 0.165 | Hematopoietic | 0.165 0.013 DB01914 0.079 0.077 DB09526 | DB01914 | |
| 0.031 | 0.576 | 0.216 | Thyroid hormone antagonist | 0.216 0.148 DB09526 | DB09526 | |
| 0.009 | 0.555 | 0.071 | Glutamate (mGluR group III) agonist | 0.071 0.015 DB09526 | DB09526 | |
| 0.032 | 0.579 | 0.198 | Thyroid hormone beta antagonist | 0.198 0.156 DB09526 | DB09526 | |
| 0.034 | 0.581 | 0.256 | 3C-like protease (Human coronavirus) inhibitor | 0.16 0.086 DB01914 0.256 0.025 DB09526 | DB09526 | |
| 0.011 | 0.563 | 0.052 | Aldosterone antagonist | 0.052 0.027 DB09526 | DB09526 | |
| 0.002 | 0.554 | 0.018 | Complement factor D inhibitor | 0.018 0.014 DB09526 | DB09526 | |
| 0.003 | 0.557 | 0.043 | Angiotensin AT1 receptor antagonist | 0.043 0.028 DB09526 | DB09526 | |
| 0.004 | 0.558 | 0.052 | GABA receptor antagonist | 0.052 0.041 DB09526 | DB09526 | |
| 0.003 | 0.559 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | 0.034 0.023 DB09526 | DB09526 | |
| 0.029 | 0.586 | 0.323 | Calpain 2 inhibitor | 0.323 0.101 DB09526 | DB09526 | |
| 0.009 | 0.567 | 0.085 | Cyclin-dependent kinase 9 inhibitor | 0.085 0.083 DB09526 | DB09526 | |
| 0.003 | 0.561 | 0.038 | Methionyl aminopeptidase 1 inhibitor | 0.038 0.014 DB09526 | DB09526 | |
| 0.003 | 0.563 | 0.034 | Carnitine palmitoyltransferase inhibitor | 0.034 0.024 DB09526 | DB09526 | |
| 0.021 | 0.585 | 0.078 | Caspase 9 inhibitor | 0.078 0.024 DB01914 | DB01914 | |
| 0.004 | 0.569 | 0.05 | Dihydrofolate reductase inhibitor | 0.045 0.027 DB09526 0.05 0.019 DBMET02101 | DBMET02101 | |
| 0.01 | 0.576 | 0.17 | MAP kinase kinase inhibitor | 0.134 0.062 DB01914 0.17 0.041 DB09526 | DB09526 | |
| 0.036 | 0.603 | 0.265 | Neuropeptide Y2 antagonist | 0.265 0.043 DB09526 | DB09526 | |
| 0.005 | 0.577 | 0.083 | Pim-3 kinase inhibitor | 0.083 0.071 DB09526 | DB09526 | |
| 0.006 | 0.578 | 0.1 | Nicotinic alpha4beta2 receptor antagonist | 0.1 0.031 DB09526 | DB09526 | |
| 0.003 | 0.576 | 0.028 | Epoxide hydrolase 1 inhibitor | 0.028 0.027 DB09526 | DB09526 | |
| 0.008 | 0.582 | 0.323 | Dyrk kinase inhibitor | 0.323 0.045 DB09526 | DB09526 | |
| 0.016 | 0.592 | 0.067 | Phosphodiesterase 1B inhibitor | 0.067 0.034 DB09526 | DB09526 | |
| 0.01 | 0.589 | 0.066 | I kappa B kinase 2 inhibitor | 0.066 0.037 DB09526 | DB09526 | |
| 0.004 | 0.585 | 0.048 | GABA A receptor antagonist | 0.048 0.044 DB09526 | DB09526 | |
| 0.007 | 0.588 | 0.042 | MAP3K5 inhibitor | 0.042 0.022 DB09526 | DB09526 | |
| 0.003 | 0.586 | 0.302 | NMDA 2 receptor antagonist | 0.158 0.015 DB09526 0.302 0.005 DBMET02101 | DBMET02101 | |
| 0.004 | 0.588 | 0.071 | Prostaglandin-E synthase inhibitor | 0.071 0.047 DB09526 | DB09526 | |
| 0.005 | 0.592 | 0.088 | Alpha 2 adrenoreceptor agonist | 0.088 0.019 DB09526 | DB09526 | |
| 0.003 | 0.589 | 0.027 | 5 Hydroxytryptamine 6 agonist | 0.027 0.023 DB09526 | DB09526 | |
| 0.004 | 0.596 | 0.123 | Protein kinase (CK2) inhibitor | 0.123 0.046 DB09526 | DB09526 | |
| 0.027 | 0.62 | 0.1 | ABCA1 expression enhancer | 0.085 0.075 DB01914 0.1 0.051 DB09526 | DB09526 | |
| 0.014 | 0.61 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | 0.069 0.03 DB09526 | DB09526 | |
| 0.001 | 0.6 | 0.034 | AMPA 1 receptor antagonist | 0.034 0.018 DB09526 | DB09526 | |
| 0.003 | 0.602 | 0.036 | AMPA 3 receptor antagonist | 0.036 0.016 DB09526 | DB09526 | |
| 0.003 | 0.604 | 0.047 | Oleamide hydrolase inhibitor | 0.047 0.03 DB09526 | DB09526 | |
| 0.003 | 0.608 | 0.027 | MAP3K8 inhibitor | 0.027 0.026 DB09526 | DB09526 | |
| 0.003 | 0.611 | 0.022 | Protease (Human cytomegalovirus) inhibitor | 0.022 0.015 DB09526 | DB09526 | |
| 0.002 | 0.613 | 0.051 | Kainate receptor antagonist | 0.051 0.021 DB09526 | DB09526 | |
| 0.005 | 0.616 | 0.039 | Histone deacetylase 9 inhibitor | 0.039 0.027 DB09526 | DB09526 | |
| 0.009 | 0.621 | 0.079 | Potassium channel (Tandem pore domain) blocker | 0.079 0.038 DB09526 | DB09526 | |
| 0.011 | 0.627 | 0.288 | Prostaglandin dehydrogenase inhibitor | 0.288 0.107 DB09526 | DB09526 | |
| 0.013 | 0.633 | 0.077 | Phosphodiesterase 1C inhibitor | 0.077 0.021 DB09526 | DB09526 | |
| 0.01 | 0.632 | 0.118 | GABA receptor agonist | 0.118 0.058 DB09526 | DB09526 | |
| 0.004 | 0.627 | 0.086 | Amidase inhibitor | 0.086 0.033 DB09526 | DB09526 | |
| 0.002 | 0.625 | 0.044 | Kainate receptor 2 antagonist | 0.044 0.019 DB09526 | DB09526 | |
| 0.006 | 0.63 | 0.05 | Potassium channel (Inward rectifier) blocker | 0.05 0.034 DB09526 | DB09526 | |
| 0.019 | 0.645 | 0.305 | 5 Hydroxytryptamine 1E antagonist | 0.305 0.027 DB09526 | DB09526 | |
| 0.004 | 0.632 | 0.047 | Histamine H1 receptor agonist | 0.047 0.024 DB09526 | DB09526 | |
| 0.018 | 0.648 | 0.17 | Neuropeptide Y1 antagonist | 0.17 0.039 DB09526 | DB09526 | |
| 0.011 | 0.641 | 0.267 | MAP kinase kinase 2 inhibitor | 0.267 0.047 DB09526 | DB09526 | |
| 0.005 | 0.639 | 0.048 | Histamine H2 receptor agonist | 0.048 0.023 DB09526 | DB09526 | |
| 0.003 | 0.641 | 0.05 | CDK5/p25 inhibitor | 0.05 0.021 DB09526 | DB09526 | |
| 0.009 | 0.65 | 0.272 | Mcl-1 antagonist | 0.272 0.029 DB09526 | DB09526 | |
| 0.014 | 0.659 | 0.125 | Activin receptor-like kinase 2 inhibitor | 0.125 0.091 DB09526 | DB09526 | |
| 0.004 | 0.651 | 0.033 | Histone deacetylase 7 inhibitor | 0.033 0.03 DB09526 | DB09526 | |
| 0.012 | 0.662 | 0.234 | I kappa B kinase epsilon inhibitor | 0.234 0.046 DB09526 | DB09526 | |
| 0.004 | 0.659 | 0.057 | Alpha 1 adrenoreceptor agonist | 0.057 0.04 DB09526 | DB09526 | |
| 0.009 | 0.666 | 0.989 | Cholecystokinin B agonist | 0.989 0 DBMET02101 | DBMET02101 | |
| 0.011 | 0.672 | 0.063 | Elastase 1 inhibitor | 0.063 0.057 DB09526 | DB09526 | |
| 0.016 | 0.678 | 0.153 | Thiol protease inhibitor | 0.124 0.109 DB01914 0.153 0.066 DB09526 | DB09526 | |
| 0.014 | 0.677 | 0.265 | DNA polymerase beta inhibitor | 0.265 0.183 DB09526 | DB09526 | |
| 0.008 | 0.672 | 0.069 | Potassium channel intermediate-conductance Ca-activated blocker | 0.069 0.027 DB09526 | DB09526 | |
| 0.003 | 0.67 | 0.132 | Protein kinase (CK2) alpha inhibitor | 0.132 0.053 DB09526 | DB09526 | |
| 0.012 | 0.681 | 0.104 | Histone deacetylase class III inhibitor | 0.104 0.086 DB09526 | DB09526 | |
| 0.004 | 0.675 | 0.027 | CDK4/cyclin D3 inhibitor | 0.027 0.022 DB09526 | DB09526 | |
| 0.012 | 0.686 | 0.241 | Breast cancer-resistant protein inhibitor | 0.15 0.024 DB09526 0.241 0.01 DBMET02101 | DBMET02101 | |
| 0.014 | 0.688 | 0.106 | Bromodomain-containing protein 2 inhibitor | 0.106 0.033 DB09526 | DB09526 | |
| 0.01 | 0.689 | 0.061 | Phosphodiesterase 1A inhibitor | 0.061 0.038 DB09526 | DB09526 | |
| 0.01 | 0.693 | 0.387 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.387 0.041 DB09526 | DB09526 | |
| 0.006 | 0.691 | 0.08 | GABA A receptor agonist | 0.08 0.063 DB09526 | DB09526 | |
| 0.007 | 0.699 | 0.08 | I kappa B kinase inhibitor | 0.08 0.061 DB09526 | DB09526 | |
| 0.003 | 0.696 | 0.033 | Renin inhibitor | 0.033 0.028 DB01914 | DB01914 | |
| 0.016 | 0.709 | 0.121 | Nav1.3 sodium channel blocker | 0.121 0.072 DB09526 | DB09526 | |
| 0.017 | 0.712 | 0.056 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.047 DB09526 | DB09526 | |
| 0.004 | 0.699 | 0.088 | Alpha adrenoreceptor agonist | 0.088 0.033 DB09526 | DB09526 | |
| 0.012 | 0.712 | 0.105 | CXC chemokine 1 receptor antagonist | 0.105 0.005 DB09526 0.058 0.025 DBMET02101 | DB09526 | |
| 0.011 | 0.712 | 0.121 | Alpha 2b adrenoreceptor antagonist | 0.121 0.058 DB09526 | DB09526 | |
| 0.005 | 0.707 | 0.117 | Glycogen synthase kinase-3 alpha inhibitor | 0.117 0.086 DB09526 | DB09526 | |
| 0.004 | 0.717 | 0.266 | NMDA 2D receptor antagonist | 0.266 0.002 DBMET02101 | DBMET02101 | |
| 0.021 | 0.736 | 0.25 | Transcription factor inhibitor | 0.25 0.187 DB09526 | DB09526 | |
| 0.004 | 0.722 | 0.077 | Acetylcholine nicotinic agonist | 0.077 0.061 DB09526 | DB09526 | |
| 0.007 | 0.729 | 0.062 | 5 Hydroxytryptamine 5A antagonist | 0.062 0.042 DB09526 | DB09526 | |
| 0.004 | 0.727 | 0.676 | NMDA 2B receptor antagonist | 0.202 0.005 DB09526 0.676 0.003 DBMET02101 | DBMET02101 | |
| 0.008 | 0.732 | 0.145 | Toll-Like receptor 9 antagonist | 0.145 0.066 DB09526 | DB09526 | |
| 0.002 | 0.73 | 0.057 | AMPA receptor antagonist | 0.057 0.027 DB09526 | DB09526 | |
| 0.001 | 0.731 | 0.017 | 3C-Like protease (MERS coronavirus) inhibitor | 0.017 0.004 DB01914 | DB01914 | |
| 0.006 | 0.741 | 0.182 | Thrombin inhibitor | 0.182 0.008 DBMET02101 | DBMET02101 | |
| 0.006 | 0.742 | 0.055 | 5 Hydroxytryptamine 5 antagonist | 0.055 0.045 DB09526 | DB09526 | |
| 0.016 | 0.755 | 0.135 | Nav1.1 sodium channel blocker | 0.135 0.039 DB09526 | DB09526 | |
| 0.005 | 0.752 | 0.165 | LIM domain kinase 1 inhibitor | 0.165 0.084 DB09526 | DB09526 | |
| 0.004 | 0.754 | 0.043 | Phosphodiesterase 3B inhibitor | 0.043 0.033 DB09526 | DB09526 | |
| 0.003 | 0.76 | 0.057 | Sphingosine 1-phosphate receptor 3 agonist | 0.057 0.013 DB01914 | DB01914 | |
| 0.008 | 0.772 | 0.078 | Sirtuin 1 inhibitor | 0.078 0.037 DB09526 | DB09526 | |
| 0.028 | 0.794 | 0.33 | Sigma receptor agonist | 0.33 0.034 DB09526 | DB09526 | |
| 0.007 | 0.777 | 0.084 | Histamine H2 receptor antagonist | 0.084 0.057 DB09526 | DB09526 | |
| 0.017 | 0.788 | 0.139 | MAP3K9 inhibitor | 0.139 0.077 DB09526 | DB09526 | |
| 0.005 | 0.793 | 0.057 | Sphingosine 1-phosphate receptor 5 agonist | 0.057 0.031 DBMET02100 | DBMET02100 | |
| 0.002 | 0.793 | 0.05 | Glutamate (mGluR1) antagonist | 0.05 0.048 DB09526 | DB09526 | |
| 0.003 | 0.795 | 0.076 | Dopamine D5 antagonist | 0.076 0.013 DB09526 | DB09526 | |
| 0.004 | 0.799 | 0.058 | Plasmin inhibitor | 0.058 0.029 DBMET02101 | DBMET02101 | |
| 0.003 | 0.801 | 0.079 | TRPA1 antagonist | 0.079 0.026 DB09526 | DB09526 | |
| 0.005 | 0.809 | 0.157 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.157 0.068 DB09526 | DB09526 | |
| 0.038 | 0.843 | 0.176 | Cyclin-dependent kinase 3 inhibitor | 0.176 0.053 DB09526 | DB09526 | |
| 0.007 | 0.815 | 0.047 | Cathepsin D inhibitor | 0.047 0.046 DB01914 | DB01914 | |
| 0.004 | 0.819 | 0.086 | Polo-like kinase-1 inhibitor | 0.086 0.071 DB09526 | DB09526 | |
| 0.008 | 0.826 | 0.057 | Autotaxin inhibitor | 0.057 0.031 DBMET02101 | DBMET02101 | |
| 0.055 | 0.874 | 0.245 | ErbB-1 antagonist | 0.245 0.054 DB09526 | DB09526 | |
| 0.005 | 0.828 | 0.159 | Focal adhesion kinase 2 inhibitor | 0.159 0.116 DB09526 | DB09526 | |
| 0.008 | 0.853 | 0.2 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.2 0.042 DB09526 | DB09526 | |
| 0.004 | 0.856 | 0.177 | Elastase inhibitor | 0.177 0.004 DBMET02101 | DBMET02101 | |
| 0.005 | 0.877 | 0.059 | Trypsin inhibitor | 0.059 0.051 DBMET02101 | DBMET02101 | |
| 0.005 | 0.881 | 0.11 | CDC-like kinase 1 inhibitor | 0.11 0.106 DB09526 | DB09526 | |
| 0.009 | 0.889 | 0.117 | Chymotrypsin inhibitor | 0.117 0.027 DBMET02101 | DBMET02101 | |
| 0.014 | 0.9 | 0.148 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.148 0.076 DB09526 | DB09526 | |
| 0.029 | 0.931 | 0.107 | Sphingosine 1-phosphate receptor 2 agonist | 0.107 0.083 DB09526 | DB09526 | |
| 0.023 | 0.929 | 0.257 | Factor V inhibitor | 0.257 0.003 DB01914 | DB01914 | |
| 0.013 | 0.923 | 0.202 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.202 0.154 DB09526 | DB09526 | |
| 0.014 | 0.932 | 0.183 | 3C-Like protease (SARS coronavirus) inhibitor | 0.183 0.005 DB01914 | DB01914 | |
| 0.015 | 0.942 | 0.191 | MAP-kinase-activated kinase 5 inhibitor | 0.191 0.115 DB09526 | DB09526 | |
| 0.005 | 0.932 | 0.417 | Streptokinase A inhibitor | 0.417 0.043 DB09526 | DB09526 | |
| 0.003 | 0.933 | 0.057 | Cyclin B2 inhibitor | 0.057 0.037 DB09526 | DB09526 | |
| 0.004 | 0.934 | 0.083 | Cyclin B3 inhibitor | 0.083 0.036 DB09526 | DB09526 | |
| 0.019 | 0.95 | 0.212 | Death-associated protein kinase 2 inhibitor | 0.212 0.027 DB09526 | DB09526 | |
| 0.003 | 0.937 | 0.056 | Cyclin B1 inhibitor | 0.056 0.049 DB09526 | DB09526 | |
| 0.023 | 0.957 | 0.16 | MAP kinase kinase 5 inhibitor | 0.16 0.115 DB01914 | DB01914 | |
| 0.004 | 0.941 | 0.129 | Glutamate receptor antagonist | 0.129 0.066 DB09526 | DB09526 | |
| 0.004 | 0.945 | 0.078 | Cathepsin B inhibitor | 0.078 0.025 DB01914 | DB01914 | |
| 0.003 | 0.945 | 0.05 | Cyclin B inhibitor | 0.05 0.046 DB09526 | DB09526 | |
| 0.003 | 0.948 | 0.044 | Kinesin-like protein 1 inhibitor | 0.044 0.019 DB09526 0.033 0.032 DBMET02101 | DB09526 | |
| 0.003 | 0.948 | 0.044 | Kinesin antagonist | 0.044 0.019 DB09526 0.033 0.032 DBMET02101 | DB09526 | |
| 0.002 | 0.948 | 0.907 | Cholecystokinin A agonist | 0.907 0.001 DBMET02101 | DBMET02101 | |
| 0.002 | 0.952 | 0.018 | Sodium/hydrogen exchanger inhibitor | 0.018 0.011 DBMET02101 | DBMET02101 | |
| 0.002 | 0.952 | 0.944 | Cholecystokinin agonist | 0.944 0.001 DBMET02101 | DBMET02101 | |
| 0.004 | 0.957 | 0.148 | M17 leucyl aminopeptidase inhibitor | 0.148 0.057 DB09526 0.123 0.075 DBMET02100 | DB09526 | |
| 0.004 | 0.967 | 0.23 | Thioredoxin glutathione reductase inhibitor | 0.23 0.148 DB09526 | DB09526 | |
| 0.003 | 0.972 | 0.092 | MAP kinase kinase 10 inhibitor | 0.092 0.022 DBMET02101 | DBMET02101 | |
| 0.002 | 0.975 | 0.682 | Cholecystokinin B antagonist | 0.682 0.002 DBMET02101 | DBMET02101 | |
| 0.002 | 0.981 | 0.065 | Factor XIa inhibitor | 0.065 0.011 DBMET02101 | DBMET02101 | |
| 0.002 | 0.984 | 0.693 | Cholecystokinin antagonist | 0.693 0.002 DBMET02101 | DBMET02101 | |
| 0.002 | 0.986 | 0.069 | Factor XI inhibitor | 0.069 0.005 DBMET02101 | DBMET02101 | |
| 0.001 | 0.988 | 0.747 | Cholecystokinin A antagonist | 0.747 0.002 DBMET02101 | DBMET02101 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |